<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceutics</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceutics</journal-id><journal-id journal-id-type="publisher-id">pharmaceutics</journal-id><journal-title-group><journal-title>Pharmaceutics</journal-title></journal-title-group><issn pub-type="epub">1999-4923</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40006538</article-id><article-id pub-id-type="pmc">PMC11859809</article-id><article-id pub-id-type="doi">10.3390/pharmaceutics17020172</article-id><article-id pub-id-type="publisher-id">pharmaceutics-17-00172</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Therapeutic Effects of Nanocoating of Apitoxin (Bee Venom) and Polyvinyl Alcohol Supplemented with Zinc Oxide Nanoparticles</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3068-0313</contrib-id><name><surname>Qanash</surname><given-names>Husam</given-names></name><xref rid="af1-pharmaceutics-17-00172" ref-type="aff">1</xref><xref rid="af2-pharmaceutics-17-00172" ref-type="aff">2</xref><xref rid="c1-pharmaceutics-17-00172" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5884-0278</contrib-id><name><surname>Bazaid</surname><given-names>Abdulrahman S.</given-names></name><xref rid="af1-pharmaceutics-17-00172" ref-type="aff">1</xref><xref rid="af2-pharmaceutics-17-00172" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Alharbi</surname><given-names>Shahad F.</given-names></name><xref rid="af1-pharmaceutics-17-00172" ref-type="aff">1</xref><xref rid="af2-pharmaceutics-17-00172" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Binsaleh</surname><given-names>Naif K.</given-names></name><xref rid="af1-pharmaceutics-17-00172" ref-type="aff">1</xref><xref rid="af2-pharmaceutics-17-00172" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5156-0647</contrib-id><name><surname>Barnawi</surname><given-names>Heba</given-names></name><xref rid="af1-pharmaceutics-17-00172" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0385-7259</contrib-id><name><surname>Alharbi</surname><given-names>Bandar</given-names></name><xref rid="af1-pharmaceutics-17-00172" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3920-4572</contrib-id><name><surname>Alsolami</surname><given-names>Ahmed</given-names></name><xref rid="af3-pharmaceutics-17-00172" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6619-0287</contrib-id><name><surname>Almashjary</surname><given-names>Majed N.</given-names></name><xref rid="af4-pharmaceutics-17-00172" ref-type="aff">4</xref><xref rid="af5-pharmaceutics-17-00172" ref-type="aff">5</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Kurek-G&#x000f3;recka</surname><given-names>Anna</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Szliszka</surname><given-names>Ewelina</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>K&#x00142;&#x000f3;sek</surname><given-names>Ma&#x00142;gorzata</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Balwierz</surname><given-names>Rados&#x00142;aw</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pharmaceutics-17-00172"><label>1</label>Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha&#x02019;il, Hail 55476, Saudi Arabia; <email>ar.bazaid@uoh.edu.sa</email> (A.S.B.); <email>alharbi.sh.f@gmail.com</email> (S.F.A.); <email>n.binsaleh@uoh.edu.sa</email> (N.K.B.); <email>h.barnawi@uoh.edu.sa</email> (H.B.); <email>b.alharbi@uoh.edu.sa</email> (B.A.)</aff><aff id="af2-pharmaceutics-17-00172"><label>2</label>Medical and Diagnostic Research Center, University of Ha&#x02019;il, Hail 55473, Saudi Arabia</aff><aff id="af3-pharmaceutics-17-00172"><label>3</label>Department of Internal Medicine, College of Medicine, University of Ha&#x02019;il, Hail 55476, Saudi Arabia; <email>a.alsolami@uoh.edu.sa</email></aff><aff id="af4-pharmaceutics-17-00172"><label>4</label>Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 22254, Saudi Arabia; <email>malmashjary@kau.edu.sa</email></aff><aff id="af5-pharmaceutics-17-00172"><label>5</label>Hematology Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 22254, Saudi Arabia</aff><author-notes><corresp id="c1-pharmaceutics-17-00172"><label>*</label>Correspondence: <email>h.qanash@uoh.edu.sa</email></corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>17</volume><issue>2</issue><elocation-id>172</elocation-id><history><date date-type="received"><day>30</day><month>11</month><year>2024</year></date><date date-type="rev-recd"><day>20</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>23</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Background/Objectives:</bold> Bee venom (BV), as a natural product, is one of the foundations of the pharmaceutical industry, through which many diseases, including serious ones, can be effectively treated. The BV nanofilm is an effective antidote delivered into the human body to target the affected area and address the issue without major side effects. In this study, we investigated the intriguing therapeutic effects of apitoxin (bee venom) used in isolation, combined with the powerful properties of zinc oxide nanoparticles. <bold>Methods and Results:</bold> BV nanofilm was evaluated using Fourier transform infrared (FTIR) spectroscopy and X-ray diffraction (XRD). The BV extract was analyzed using mass spectrometry (MS), which identified 84 active components present at varying concentrations. BV was treated with both polyvinyl alcohol (PVA) and zinc oxide nanoparticles (ZNPs) to increase the intensity of OH and CH<sub>2</sub> groups and to enhance the dispersion of C=O. BV has demonstrated anti-type 2 diabetes activity by inhibiting &#x003b1;-amylase and &#x003b1;-glucosidase, which are starch-degrading enzymes. The nanofilm is an active mixture of BV, PVA, and ZNPs, which exhibited the highest antidiabetic activity with IC<sub>50</sub> values of 30.33 &#x003bc;g/mL and 5.55 &#x003bc;g/mL for the inhibition of &#x003b1;-amylase and &#x003b1;-glucosidase, compared to IC<sub>50</sub> of 51.69 &#x000b5;g/mL and IC<sub>50</sub> of 7.30 &#x000b5;g/mL for BV, respectively. The nanofilm also showed higher anti-inflammatory activity by inhibiting red blood cell (RBC) hemolysis, with an IC<sub>50</sub> of 16.99 &#x003bc;g/mL in comparison to IC<sub>50</sub> of 72.99 &#x000b5;g/mL for BV alone. The nanofilm demonstrated broad-spectrum antimicrobial activity, effectively targeting both Gram-positive (<italic toggle="yes">Staphylococcus aureus</italic> ATCC 6538 and <italic toggle="yes">Bacillus subtilis</italic> ATCC 6633) and Gram-negative bacteria (<italic toggle="yes">Salmonella typhi</italic> ATCC 6539, <italic toggle="yes">Escherichia coli</italic> ATCC 8739). Furthermore, increased antioxidant activity was recorded by inhibiting the 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging effect with an IC<sub>50</sub> of 4.26 &#x003bc;g/mL and 19.43 &#x003bc;g/mL for nanofilm and BV, respectively. BV was found to be more toxic to liver tissue (HepG2 cell line) than nanofilm, with IC<sub>50</sub> values of 18.5 &#x000b1; 0.08 &#x003bc;g/mL and 52.27 &#x000b1; 0.7 &#x003bc;g/mL, respectively. The BV extract displayed higher toxicity to liver tissue (2.3%) with 97.7% viability at 250 &#x003bc;g/mL, compared to nanofilm, which showed 0.09% toxicity and 99.9% viability at the same concentration. <bold>Conclusions:</bold> the BV nanofilm emerges as a promising alternative medicine, offering an innovative solution for treating various diseases through its high concentration of therapeutically active compounds and effortless targeting delivery.</p></abstract><kwd-group><kwd>bee venom</kwd><kwd>therapeutic activity</kwd><kwd>polyvinyl alcohol</kwd><kwd>nanofilm</kwd><kwd>zinc oxide</kwd></kwd-group><funding-group><award-group><funding-source>Scientific Research Deanship at University of Ha&#x02019;il, Saudi Arabia</funding-source><award-id>RG-24 037</award-id></award-group><funding-statement>This research was funded by the Scientific Research Deanship at University of Ha&#x02019;il, Saudi Arabia through project number RG-24 037.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmaceutics-17-00172"><title>1. Introduction</title><p>Drug therapy has achieved great success, especially in the last century following the development of biotechnology. However, drug therapy has side effects, some of which are severe, and some are common, including allergies to active ingredients. Therefore, it is necessary to seek alternative medicine to avoid severe side effects and provide highly effective treatment for diseases. Bee products, particularly bee venom (BV), are effective and safe natural medicines, capable of curing many diseases completely without side effects.</p><p>Apitherapy is one of the natural and effective approaches used since ancient times. Bee venom (BV) is a natural substance produced by bees, commonly used in the treatment of various diseases, particularly for its wound-healing properties [<xref rid="B1-pharmaceutics-17-00172" ref-type="bibr">1</xref>]. A wide range of diseases can be treated with BV due to its various therapeutically active compounds, including biogenic amines, phospholipase A2, essential peptides (melittin, apamin, adolapin, mast cell-degranulating peptides), and water-soluble nitrogen-containing substances [<xref rid="B2-pharmaceutics-17-00172" ref-type="bibr">2</xref>]. Despite being a small peptide composed of 26 amino acids, melittin is the predominant component of BV [<xref rid="B3-pharmaceutics-17-00172" ref-type="bibr">3</xref>]. BV can be administered in different ways depending on the condition being treated, such as in the form of a cream, ointment, injection, acupuncture, or direct bee sting [<xref rid="B4-pharmaceutics-17-00172" ref-type="bibr">4</xref>]. However, BV acupuncture is the most common method, wherein acupuncture points are directly injected with diluted BV. Therefore, this method is often used as an alternative treatment for patients suffering from pain and inflammatory diseases, such as rheumatoid arthritis, osteoarthritis, and neuritis [<xref rid="B5-pharmaceutics-17-00172" ref-type="bibr">5</xref>,<xref rid="B6-pharmaceutics-17-00172" ref-type="bibr">6</xref>]. In a broad sense, BV is considered a magic drug due to its multiple therapeutic effects in a short time, including antibacterial, antiviral, and anti-inflammatory activities. Furthermore, BV exhibits antiproliferative activity against cancer cells in various human organs [<xref rid="B6-pharmaceutics-17-00172" ref-type="bibr">6</xref>]. BV is a mixture of water (88%), glucose, fructose, phospholipids, and proteins, with an acidic pH of 4.5 to 5.5. This mixture is a transparent, odorless liquid with a bitter taste and can dry easily, even at room temperature. Although BV is a transparent liquid, it can oxidize in air to form grayish-white crystals and may appear yellow under light [<xref rid="B7-pharmaceutics-17-00172" ref-type="bibr">7</xref>].</p><p>Nanotechnology is a promising new approach used in many fields, including the pharmaceutical industry. Nanoparticles (NPs) of active ingredients are more effective and are delivered to the target site using nanoparticle-based drug delivery systems (DDSs). NPs must be stabilized by adding a strong, nonionic stabilizer, such as polyvinyl alcohol (PVA), which provides stable colloidal dispersion through stereostatic stabilization [<xref rid="B8-pharmaceutics-17-00172" ref-type="bibr">8</xref>]. Although PVA is a water-soluble polyhydroxylated polymer that is easy to prepare, chemically stable, and biodegradable, its industrial use is limited by poor mechanical properties and thermal stability. Therefore, the mechanical properties and processing of PVA should be improved prior to its use in nanotechnology [<xref rid="B9-pharmaceutics-17-00172" ref-type="bibr">9</xref>]. PVA is one of the most widely used stabilizers, promoting the production of small, stable molecules with a narrow size distribution. PVA has residual stability, which allows it to remain attached to the surface of polymer NPs even after repeated washing, forming a stabilizing layer that improves their resistance to freezing without the addition of a freeze protectant [<xref rid="B10-pharmaceutics-17-00172" ref-type="bibr">10</xref>].</p><p>Zinc oxide nanoparticles (ZNPs) are widely used in nanotechnology due to their high optical, magnetic, and electrical efficiency. ZNPs are utilized in the manufacture of many products, including disinfectants for their antibacterial activity, as well as in anti-UV applications, deodorants, pharmaceuticals, electronics, gas sensors, and more [<xref rid="B11-pharmaceutics-17-00172" ref-type="bibr">11</xref>,<xref rid="B12-pharmaceutics-17-00172" ref-type="bibr">12</xref>,<xref rid="B13-pharmaceutics-17-00172" ref-type="bibr">13</xref>]. However, ZNPs have negative effects on mammals with daily use, including genotoxic effects in the pancreas, stomach, liver, spleen, and thymus [<xref rid="B14-pharmaceutics-17-00172" ref-type="bibr">14</xref>]; abnormalities in spermatogenesis; testicular damage; and decreased serum testosterone levels. Furthermore, ZNPs increase cytokine levels in the serum, leading to severe inflammation [<xref rid="B15-pharmaceutics-17-00172" ref-type="bibr">15</xref>]. Fortunately, BV has an inhibitory effect on ZNPs that cause neuropathy and neurological abnormalities. The beneficial effects of BV are attributed to its ability to modulate neurotransmitter levels, maintain brain zinc concentration, enhance antioxidant activity, and reduce the expression of GAP-43 and neurofilaments in brain tissue [<xref rid="B16-pharmaceutics-17-00172" ref-type="bibr">16</xref>]. ZNPs are frequently utilized in the production of various products, particularly in the medical and pharmaceutical sectors, owing to their exceptional properties, such as biocompatibility, UV protection, antimicrobial activity, enhanced thermal conductivity, high bonding energy, and elevated refractive index [<xref rid="B17-pharmaceutics-17-00172" ref-type="bibr">17</xref>]. Metal oxide NPs are promising biomaterials with low toxicity and low accumulation. ZNPs are bioactive NPs with a unique safety profile and dermatological therapeutic properties as well [<xref rid="B18-pharmaceutics-17-00172" ref-type="bibr">18</xref>,<xref rid="B19-pharmaceutics-17-00172" ref-type="bibr">19</xref>]. This study aims to reveal the therapeutic potential of bee venom (BV) as a natural product without side effects, as BV acts as a broad-spectrum antibiotic, anti-inflammatory, antioxidant, and antidiabetic, all without causing critical toxicity to liver cells, which are responsible for absorbing toxins from the body and excreting them through feces.</p></sec><sec id="sec2-pharmaceutics-17-00172"><title>2. Materials and Methods</title><sec id="sec2dot1-pharmaceutics-17-00172"><title>2.1. Materials Used in the Study</title><p>A high sterile apitoxin (bee venom) was collected from a beekeeper, Mr. Mohammad A. Alaamri, Hail, Saudi Arabia. PVA (SIGMA-Aldrich Chemie GmbH, Taufkirchen, Germany, MW 146,000&#x02013;186,000, 99+% hydrolyzed) and zinc acetate dihydrate (LOBA Chemie Pvt Ltd., Mumbai, India) were obtained, prepared, and stored according to the package instructions.</p></sec><sec id="sec2dot2-pharmaceutics-17-00172"><title>2.2. Collection, Storage, and Utilization of Bee Venom</title><p>The electric bee venom collection device, designed for in-hive use, comprises a device equipped with closely spaced wires connected to an electric current supplied by lithium batteries. To ensure the purity and quality of the collected bee venom for human use, a glass plate covered with food-grade shrink wrap is placed between the wires. The device is strategically positioned in crowded hives during periods of abundant foraging rich in pollen and nectar. This timing ensures that the collected venom adheres to standard specifications, specifically containing 50% of its dry weight in melittin. The electric bee venom device remains in the hive for a duration of 8&#x02013;12 h. After this period, the device is carefully removed and transferred to a cool, shaded environment. To prevent contamination, beekeepers wear masks and gloves during the collection process. The food-grade shrink wrap covering the glass plate is removed, and the dry venom located in the center of the plate is meticulously scraped off using a sterilized scalpel. Venom along the edges of the glass plate, often contaminated with propolis and pollen grains, is discarded. The collected dry venom is stored in glass containers and placed in a freezer, where it maintains a shelf life of no less than two years. This harvested venom is subsequently utilized to produce various products, including creams, sublingual drops, and injection ampoules.</p></sec><sec id="sec2dot3-pharmaceutics-17-00172"><title>2.3. Formulation of Bioactive Film</title><p>A PVA solution (2% <italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) was prepared in a clean glass container by dissolving 2 g of PVA in 100 mL of distilled water. The PVA solution was supplemented with 0.1 g of BV while stirring for 3 h at 37 &#x000b0;C, resulting in a solution named PVA/BV. Zinc acetate dihydrate (0.01 g) was dissolved in 10 mL of distilled water and then added to 20 mL of the PVA/BV solution, with the mixture stirred overnight at 37 &#x000b0;C. The solution was pooled and subjected to ultrasonication using an ultrasonic probe for 5 min, followed by several washes with ethanol; this solution was named nanofilm. The PVA, PVA/BV, and nanofilm solutions were poured into 10 mm Teflon dishes and dried in a vacuum oven at 40 &#x000b0;C for 5 h [<xref rid="B18-pharmaceutics-17-00172" ref-type="bibr">18</xref>].</p></sec><sec id="sec2dot4-pharmaceutics-17-00172"><title>2.4. Characterization Techniques</title><p>In the current study, several techniques were employed to evaluate the nanofilm. X-ray diffraction (XRD) patterns of the as-prepared compounds were obtained using an Empyrean PANalytical X-ray diffractometer [&#x003bb; = 1.5418 &#x000c5; (Bruker Nederland BV, Leiderdorp, The Netherlands)] with filtered Cu K&#x003b1; radiation (45 kV and 30 mA). The diffraction angle (2&#x003b8;) was scanned in the range of 10&#x000b0; to 80&#x000b0;, with a step size of 0.026&#x000b0; and a counting time of 20 s per step [<xref rid="B20-pharmaceutics-17-00172" ref-type="bibr">20</xref>]. Furthermore, Fourier transform infrared spectroscopy (FTIR) spectra were recorded using a high-resolution FTIR spectrometer (JASCO FT/IR 460 Plus Spectrometer, Hachioji, Japan) [<xref rid="B21-pharmaceutics-17-00172" ref-type="bibr">21</xref>]. Additionally, transmission electron microscopy (TEM) was conducted using a TEM-1230 (JEOL Corporation, Akishima, Tokyo, Japan) at an accelerating voltage of 100 kV [<xref rid="B22-pharmaceutics-17-00172" ref-type="bibr">22</xref>]. Finally, scanning electron microscopy (SEM) (JSM-T20 JEOL, Chiyoda, Japan) was used to assess the morphology of the composites. The composite samples were mounted on a standard sample tray and coated with a thin layer of gold through deposition [<xref rid="B23-pharmaceutics-17-00172" ref-type="bibr">23</xref>].</p></sec><sec id="sec2dot5-pharmaceutics-17-00172"><title>2.5. Mechanical Properties</title><p>The tensile strength (&#x003c3;R) and elongation at break (&#x003b5;R) were recorded using a Zwick electronic tensile testing machine (Zwick/Roell, Model Z010, Ulm, Germany). The hardness (Hv) was measured with a Shimadzu standard Vickers hardness tester (Kyoto, Japan), HP M-2 E precision hardness tester (344-04109-22) (Bruker Japan, Yokohama, Japan), applying a load of 1.96 N for 15 s on a sample with a thickness of approximately 1.5 mm [<xref rid="B24-pharmaceutics-17-00172" ref-type="bibr">24</xref>].</p></sec><sec id="sec2dot6-pharmaceutics-17-00172"><title>2.6. In Vitro Assay of &#x003b1;-Amylase Inhibitory Activity</title><p>Alpha-amylase inhibitory activity was evaluated in vitro using the 3,5-dinitrosalicylic acid (DNSA) method [<xref rid="B25-pharmaceutics-17-00172" ref-type="bibr">25</xref>]. The extract was first dissolved in a small amount of 10% DMSO and then further diluted in a buffer solution (Na<sub>2</sub>HPO<sub>4</sub> 0.02 M, NaCl 0.006 M at pH 6.9) to achieve a concentration range of 1.9 to 1000 &#x003bc;g/mL. The extract (200 &#x000b5;L) was mixed with &#x003b1;-amylase solution (200 &#x003bc;L; 2 U/mL) and incubated for 10 min at 30 &#x000b0;C. After incubation, 200 &#x003bc;L of starch solution was added to each tube and incubated for an additional 3 min. Then, 200 &#x003bc;L of DNSA (containing 12 g of sodium potassium tartrate tetrahydrate, 8.0 mL of 2 M NaOH, and 20 mL of 96 mM 3,5-dinitrosalicylic acid solution) was added, and the mixture was boiled for 10 min in a water bath at 85&#x02013;90 &#x000b0;C to stop the reaction. The mixture was allowed to cool to room temperature and then diluted with 5 mL of distilled water. The absorbance of the mixture was measured at 540 nm using a Biosystem 310 UV&#x02013;Vis spectrophotometer (BIOBASE LLC, Jinan, China). A blank was prepared using only the plant extract without the enzyme solution. Alpha-amylase inhibitory activity was calculated using the following equation. The percentage of &#x003b1;-amylase inhibition was plotted against the concentration of the extract, and the IC<sub>50</sub> value (the concentration required to inhibit 50% of the enzyme activity) was determined from the graph.
<disp-formula id="FD1-pharmaceutics-17-00172"><mml:math id="mm1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">y</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mo>%</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mn>100</mml:mn><mml:mo>%</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:mfenced><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mn>100</mml:mn><mml:mo>%</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mo>(</mml:mo><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="sec2dot7-pharmaceutics-17-00172"><title>2.7. In Vitro Assay of &#x003b1;-Glucosidase Inhibitory Activity</title><p>The extract was tested for &#x003b1;-glucosidase inhibitory activity using a modified method based on the protocol by Pistia and Hollingsworth [<xref rid="B26-pharmaceutics-17-00172" ref-type="bibr">26</xref>]. Different concentrations (1.97 to 1000 &#x003bc;g/mL) of the extract (50 &#x003bc;L) were incubated with 10 &#x003bc;L of a 1 U/mL &#x003b1;-glucosidase solution (SIGMA EMD Millipore Corporation, Burlington, MA, USA) for 20 min at 37 &#x000b0;C, along with 125 &#x003bc;L of a 0.1 M phosphate buffer solution (pH 6.8). After incubation, 20 &#x003bc;L of 1 M p-nitrophenyl-&#x003b1;-D-glucopyranoside (pNPG) was added to initiate the reaction, and the mixture was incubated for an additional 30 min. The reaction was terminated by adding 50 &#x003bc;L of 0.1 N Na<sub>2</sub>CO<sub>3</sub>, and the absorbance was measured at 540 nm using a Biosystem 310 UV&#x02013;Vis spectrophotometer. A blank was prepared using only the plant extract without the enzyme solution. Alpha-glucosidase inhibitory activity was calculated using the following equation. The percentage of &#x003b1;-glucosidase inhibition was plotted against the concentration of the extract, and IC<sub>50</sub> values (the concentration required to inhibit 50% of the enzyme activity) were derived from the graph. One unit of &#x003b1;-glucosidase is defined as the amount of enzyme required to release one &#x003bc;mol of product (p-nitrophenol) from the substrate (pNPG) per minute.
<disp-formula id="FD2-pharmaceutics-17-00172"><mml:math id="mm2" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mo>%</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mo>=</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mn>100</mml:mn><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mo>(</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">k</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">k</mml:mi></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="sec2dot8-pharmaceutics-17-00172"><title>2.8. In Vitro Assay of Anti-Inflammatory Activity</title><p>Fresh, healthy blood (3 mL) was collected into heparinized tubes and centrifuged at 3000&#x000d7; <italic toggle="yes">g</italic> for 10 min. The erythrocyte granules were lysed using an equal volume of saline to the supernatant. The erythrocyte sediment was measured and reconstituted into a 40% <italic toggle="yes">v/v</italic> suspension with an isotonic buffer (10 mM sodium phosphate buffer, 0.2 g NaH<sub>2</sub>PO<sub>4</sub>, 1.15 g Na<sub>2</sub>HPO<sub>4</sub>, 9 g NaCl, pH 7.4 in 1.0 L distilled water). The reconstituted erythrocytes (resuspended supernatant) were then used for further experiments [<xref rid="B27-pharmaceutics-17-00172" ref-type="bibr">27</xref>]. Different concentrations of the extract (100, 200, 400, 600, 800, 1000 &#x003bc;g/mL) were dissolved in 5 mL of distilled water to create hypotonic solutions in two pairs of centrifuge tubes (for each concentration). Isotonic solutions (5 mL) containing varying concentrations of the extract (3.9&#x02013;1000 &#x003bc;g/mL) were prepared in two pairs of centrifuge tubes (for each concentration). The control tube contained 5 mL of distilled water and 5 mL of indomethacin. A 0.1 mL red blood cell suspension was added to each tube and mixed gently. The mixtures were incubated for 1 h at room temperature and then centrifuged for 3 min at 1300&#x000d7; <italic toggle="yes">g</italic>. The absorbance of the hemoglobin-containing supernatant was measured at 540 nm using a UV&#x02013;visible spectrophotometer (Milton Roy, Houston, TX, USA). The hemolysis rate was calculated, assuming that hemolysis in the presence of distilled water was 100% [<xref rid="B28-pharmaceutics-17-00172" ref-type="bibr">28</xref>]. The percentage of hemolysis inhibition using the extract was calculated using the following equation:<disp-formula id="FD3-pharmaceutics-17-00172"><mml:math id="mm3" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">y</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mo>%</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mo>(</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mn>2</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mn>3</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula>
where Abs. 1 is the absorbance of the test sample in isotonic solution, Abs. 2 is the absorbance of the test sample in hypotonic solution, and Abs. 3 is the absorbance of the control sample in hypotonic solution.</p></sec><sec id="sec2dot9-pharmaceutics-17-00172"><title>2.9. Determination of Minimum Inhibitory Concentration (MIC)</title><p>The minimum inhibitory concentrations (MICs) of the tested extracts were determined using the microdilution method with Mueller&#x02013;Hinton broth supplemented with lysed horse blood. The extracts were serially diluted twofold to achieve final concentrations ranging from 0.98 to 1000 &#x003bc;g/mL. Each dilution was distributed into the broth of individual wells. Fresh microbial cultures were prepared in a 0.85% sterilized NaCl solution to reach a final density of 3 &#x000d7; 10<sup>6</sup> CFU/mL and were added to the wells. After 72 h of incubation at 35 &#x000b0;C under microaerobic conditions (15% CO<sub>2</sub>), the MIC was visually determined as the lowest extract concentration that completely inhibited the growth of the reference strain. Each microplate also included a positive control (inoculum only, no extract) and a negative control (extract only, no inoculum). Negative controls contained two serial dilutions (0.98&#x02013;1000 &#x003bc;g/mL) of the test organism without inoculation to establish a baseline and avoid turbidity caused by the test material. A portion of the positive control was included to establish the initial concentration of the organism used. Turbidity was measured at 630 nm using a Biotech 800 TS microplate reader (Agilent, Lexington, MA, USA). The growth in wells containing antimicrobial agents was compared to that in growth control wells (not antimicrobial agents) and negative control wells. Growth endpoints were determined based on these comparisons. For the test to be valid, acceptable growth must be observed in the growth control wells.</p></sec><sec id="sec2dot10-pharmaceutics-17-00172"><title>2.10. Determination of Minimum Bactericidal Concentration (MBC)</title><p>The minimum bactericidal concentration (MBC) was determined by transferring 100 &#x000b5;L of microbial culture from each well showing complete inhibition of growth, as well as from the last positive control and the growth control, onto Mueller&#x02013;Hinton agar plates supplemented with 10% sheep blood. The plates were incubated at 35 &#x000b0;C for 72 h under microaerophilic conditions. The MBC/MIC ratios were then calculated to assess whether the analyzed extracts exhibited a bactericidal or bacteriostatic effect [<xref rid="B29-pharmaceutics-17-00172" ref-type="bibr">29</xref>].</p></sec><sec id="sec2dot11-pharmaceutics-17-00172"><title>2.11. In Vitro Assay of Antimicrobial Activity</title><p>The antimicrobial activity was determined in vitro using the agar well diffusion method [<xref rid="B30-pharmaceutics-17-00172" ref-type="bibr">30</xref>]. Nutrient agar (for bacteria) or Sabouraud agar (for fungi) plates, seeded with the test microorganisms, were prepared and placed in the refrigerator for 1 h to reduce microbial growth. The agar surface was punctured to create several wells (6&#x02013;8 mm) using a sterile cork borer. Each well was then inoculated with 100 &#x003bc;L of antimicrobial agents and test solutions. The inhibition zone around the well, indicating the inhibitory activity of the antimicrobial agent or test solution, was measured in millimeters, consistent with antimicrobial activity.</p></sec><sec id="sec2dot12-pharmaceutics-17-00172"><title>2.12. In Vitro Assay of Antioxidant Activity</title><p>The antioxidant (free radical scavenging) activity was assessed in vitro using the DPPH assay [<xref rid="B31-pharmaceutics-17-00172" ref-type="bibr">31</xref>]. A 0.1 mM DPPH solution was prepared and mixed with ethanol, then 1 mL of this solution was added to 3 mL of the test sample at varying concentrations (3.9, 7.8, 15.62, 31.25, 62.5, 125, 250, 500, and 1000 &#x003bc;g/mL). The mixture was shaken thoroughly and allowed to stand at room temperature for 30 min. Absorbance was measured at 517 nm using a Milton Roy UV&#x02013;Vis spectrophotometer. Ascorbic acid served as the standard, and the experiment was conducted in triplicate. The IC<sub>50</sub> was determined from the log dose&#x02013;inhibition curve. A lower absorbance of the reaction mixture reflected higher free radical scavenging activity. The percentage of DPPH scavenging was calculated using the following equation:<disp-formula id="FD4-pharmaceutics-17-00172"><mml:math id="mm4" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">H</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mo>%</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="sec2dot13-pharmaceutics-17-00172"><title>2.13. LC-ESI-MS/MS Analysis</title><p>Samples were analyzed using liquid chromatography&#x02013;electrospray ionization&#x02013;tandem mass spectrometry (LC-ESI-MS/MS) on a SCIEX Triple Quad 5500+ MS/MS system (SCIEX, Framingham, MA, USA), coupled with an ExionLC AC system (SCIEX, Framingham, MA, USA) for separation and an electrospray ionization (ESI) source for detection [<xref rid="B32-pharmaceutics-17-00172" ref-type="bibr">32</xref>]. Separation was achieved on an Ascentis<sup>&#x000ae;</sup> Express 90 &#x000c5; C18 column (2.1 &#x000d7; 150 mm, 2.7 &#x003bc;m) (SIGMA EMD Millipore Corporation, Burlington, MA, USA). The mobile phase consisted of two solvents: (A) 5 mM ammonium formate (pH 3) and (B) acetonitrile (LC grade). The gradient program for the mobile phase was as follows: 0&#x02013;1 min, 5% B; 5&#x02013;20 min, 5% to 100% B; 20&#x02013;25 min, 100% B; 25.01&#x02013;30 min, back to 5% B. The flow rate was set at 0.3 mL/min, and the injection volume was 5 &#x003bc;L. For MS/MS analysis, negative ionization mode (EMS-IDA-EPI) was used for MS1 scans between 100 and 1000 Da with the following parameters: curtain gas at 25 psi, ion spray voltage at 5500 V, source temperature at 500 &#x000b0;C, and source gases 1 and 2 set to 45 psi. MS2 scans were performed from 50 to 1000 Da with a decoupling potential of 80 V and a collision energy of 35 eV.</p></sec><sec id="sec2dot14-pharmaceutics-17-00172"><title>2.14. Determination of Cytotoxicity and Viability of BV on the HepG2 Cell Line</title><p>A cell suspension (1 &#x000d7; 10<sup>5</sup> cells/mL or 100 &#x003bc;L per well) was seeded into a 96-well tissue culture plate and incubated at 37 &#x000b0;C for 24 h to allow the formation of a complete monolayer. Once the monolayer was fully formed, the growth medium was removed, and the cells were washed twice with washing medium. The sample was then diluted twice in maintenance medium (RPMI) containing 2% serum, and 0.1 mL of each dilution was added to separate wells, leaving three wells as controls [<xref rid="B33-pharmaceutics-17-00172" ref-type="bibr">33</xref>]. The plate was incubated at 37 &#x000b0;C for 24 h and subsequently examined for cytotoxicity, which was indicated by physical signs, such as partial or complete loss of the monolayer, as well as cell rounding, shrinkage, or degranulation [<xref rid="B34-pharmaceutics-17-00172" ref-type="bibr">34</xref>]. A solution of MTT (3-4,5-dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide) (5 mg/mL in phosphate buffer) was prepared (BIO BASIC INC, Markham, ON, Canada). To each well of the tissue culture plate, 20 &#x003bc;L of the MTT solution was added and incubated at 37 &#x000b0;C with shaking at 150 rpm for 5 min to ensure thorough mixing with the medium. The plates were then incubated under the specified conditions (37 &#x000b0;C, 5% CO<sub>2</sub>) for 4 h, allowing the metabolites to fully develop. The medium was removed, and the plates were dried on paper towels to eliminate any residue. The metabolites in the MTT solution were then resuspended in 200 &#x003bc;L DMSO, stirred at 150 rpm for 5 min at 37 &#x000b0;C, and mixed completely. Absorbance was measured at 560 nm, with background subtraction at 620 nm [<xref rid="B35-pharmaceutics-17-00172" ref-type="bibr">35</xref>,<xref rid="B36-pharmaceutics-17-00172" ref-type="bibr">36</xref>]. Morphological changes can be observed on the cell surface or within the cytoskeleton of the cell lines. Damaged cells typically show a reduction in size due to significant loss of proteins and ions, resulting from altered permeability to sodium and potassium. Necrotic cells appear swollen, with chromatin clumping and the loss of the nuclear membrane. In contrast, apoptotic cells appear shrunken, with nuclear condensation followed by fragmentation of the nucleolus.</p></sec><sec id="sec2dot15-pharmaceutics-17-00172"><title>2.15. Statistical Analysis</title><p>The results (triads) are presented as mean &#x000b1; standard deviation (SD) and mean &#x000b1; standard error (SE), calculated using Microsoft Excel 365 and SPSS v.25. Quantitative data with a normal distribution across different treatments were analyzed using one-way analysis of variance (ANOVA) followed by Tukey&#x02019;s post hoc test, with a significance level set at 0.05.</p></sec></sec><sec sec-type="results" id="sec3-pharmaceutics-17-00172"><title>3. Results and Discussion</title><sec id="sec3dot1-pharmaceutics-17-00172"><title>3.1. Structural and Interactional Insight: FTIR and XRD Characterization of Crystallinity in PVA, BV, and ZnO Nanofilm</title><p>The nanofilm formulation was evaluated using physicochemical analysis, including FTIR and XRD. In the FTIR spectra, the PVA spectrum exhibited a typical pure PVA profile with peaks at 3260 cm<sup>&#x02212;1</sup> (OH stretching), 2939 cm<sup>&#x02212;1</sup> (CH<sub>2</sub>), 2905 cm<sup>&#x02212;1</sup> (CH<sub>2</sub>), 1735 cm<sup>&#x02212;1</sup> (C=O), 1555 cm<sup>&#x02212;1</sup> (C-H/O-H), and 1419 cm<sup>&#x02212;1</sup> (C-H/O-H) (<xref rid="pharmaceutics-17-00172-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B37-pharmaceutics-17-00172" ref-type="bibr">37</xref>]. The BV spectrum displayed bands at 3291 cm<sup>&#x02212;1</sup> that correspond to an overlap of N-H and O-H, 2930 cm<sup>&#x02212;1</sup> related to the stretching vibration of C-H, and 1640 and 1532 cm<sup>&#x02212;1</sup> assigned to amide I and II, respectively [<xref rid="B38-pharmaceutics-17-00172" ref-type="bibr">38</xref>]. In this study, the FTIR spectrum of the PVA/BV blend showed increased intensity in the OH and CH<sub>2</sub> bands, as well as a dispersion of C=O for PVA and amide I for BV. These changes affirm the interaction between PVA and BV. The addition of ZNPs affected the intensity of OH and CH<sub>2</sub> groups, leading to a decrease, and the ZnO fingerprint bands were observed at 655 and 487 cm<sup>&#x02212;1</sup> in M-O and M-O-M, respectively [<xref rid="B39-pharmaceutics-17-00172" ref-type="bibr">39</xref>]. Indeed, the FTIR spectra confirmed the successful formulation of the nanofilm.</p><p>The XRD pattern of pure PVA film revealed two characteristic peaks at 21&#x000b0; and 41&#x000b0;, which are associated with the semi-crystalline nature of PVA (<xref rid="pharmaceutics-17-00172-f002" ref-type="fig">Figure 2</xref>) [<xref rid="B40-pharmaceutics-17-00172" ref-type="bibr">40</xref>]. Intra- and intermolecular hydrogen bonding in PVA supports its semi-crystalline structure. This type of bonding can occur within individual monomer units or between separate monomer units. The BV pattern exhibited amorphous behavior with two peaks at 9.1&#x000b0; and 19.27&#x000b0;, which is consistent with the literature [<xref rid="B41-pharmaceutics-17-00172" ref-type="bibr">41</xref>]. Furthermore, the PVA/BV composition showed a pattern with two peaks at 1.9&#x000b0; and 41.2&#x000b0;, indicating the dominance of PVA crystallinity in the PVA/BV sample. Although ZNPs were added in small amounts (50 ppm), it was observed in the nanofilm pattern, which showed peaks at 32.5&#x000b0;, 34.4&#x000b0;, 36&#x000b0;, 46&#x000b0;, and 55&#x000b0;. All pronounced peaks can be indexed to the wurtzite zinc oxide structure (JCPDS data card no.: 36-1451) [<xref rid="B42-pharmaceutics-17-00172" ref-type="bibr">42</xref>]. This study utilized the XRD technique to confirm the crystallization of the nanofilm and its pure materials, supporting the presence of ZNP doping in the film structure [<xref rid="B43-pharmaceutics-17-00172" ref-type="bibr">43</xref>]. Moreover, the physicochemical analysis validated the molecular structure of the formulated nanoform.</p></sec><sec id="sec3dot2-pharmaceutics-17-00172"><title>3.2. Morphological Characterization of PVA, BV, and ZnO Nanofilm Through Scanning and Transmission Electron Microscopy</title><p>After nanofilm formulation, the surface morphology was observed using FE-SEM of pure PVA (<xref rid="pharmaceutics-17-00172-f003" ref-type="fig">Figure 3</xref>). The PVA image showed a smooth surface of pure, nonsteroidal PVA [<xref rid="B44-pharmaceutics-17-00172" ref-type="bibr">44</xref>]. However, the nanofilm formulation affected the surface morphology, which displayed numerous axes and depressions in the low magnification image. The high magnification image revealed a more porous surface due to BV integration, as well as some axes resembling coated spheres attached to the surface, indicating ZNPs that hindered the molecular structure of the nanofilm matrix. Furthermore, the EDX chart of BV presented elemental carbon, oxygen, nitrogen, phosphorus, sulfur, chloride, sodium, and potassium. These elements are related to the protein structure and other mineral elements. Additionally, the XRD pattern of the nanofilm indicated the removal of compositions, such as carbon, oxygen, sodium, and zinc. The peak oxygen density of the nanofilm was higher than that of pure PVA due to the formulation of ZNPs.</p><p>TEM images showed that both high and low magnification images displayed ZNPs as small irregular spheres with a size of approximately 17.1 nm (<xref rid="pharmaceutics-17-00172-f004" ref-type="fig">Figure 4</xref>). Specifically, TEM revealed a matrix consisting of at least two phases that could be PVA and BV, including dark particles that were homogeneously distributed ZNPs. These observations confirmed the formulation of nanostructured nanofilm with doped ZNPs of irregular size and homogeneous distribution. This nanofilm formulation holds promise as an alternative treatment in the pharmaceutical industry.</p></sec><sec id="sec3dot3-pharmaceutics-17-00172"><title>3.3. PVA, BV, and ZnO Nanofilm: A Potent Inhibitor of &#x003b1;-Amylase and &#x003b1;-Glucosidase for Enhanced Antidiabetic Efficacy</title><p>The breakdown of starch by starch-degrading enzymes, such as &#x003b1;-amylase and &#x003b1;-glucosidase, results in elevated blood sugar levels in diabetics. Consequently, inhibiting these enzymes serves as an antidiabetic strategy for type 2 diabetes. The same concentrations of acarbose, nanofilm, BV, PVA-blank (PVA-B), and PVA-BV were tested for their &#x003b1;-amylase inhibitory effects, with the mean absorbance measured at 540 nm. BV exhibited antidiabetic activity by inhibiting &#x003b1;-amylase, with an IC<sub>50</sub> of 51.69 &#x003bc;g/mL, compared to the IC<sub>50</sub> of acarbose, which served as a standard &#x003b1;-amylase inhibitor at 4.01 &#x003bc;g/mL. However, when BV was loaded onto PVA, it showed lower antidiabetic activity, inhibiting &#x003b1;-amylase with an IC<sub>50</sub> of 182 &#x003bc;g/mL (<xref rid="pharmaceutics-17-00172-t001" ref-type="table">Table 1</xref>). PVA-B displayed negligible inhibition of &#x003b1;-amylase, with no measurable IC<sub>50</sub> value, indicating no antidiabetic activity. In contrast, nanofilm (BV, PVA, ZNPs) demonstrated the highest antidiabetic activity by inhibiting &#x003b1;-amylase with an IC<sub>50</sub> of 30.33 &#x003bc;g/mL. Ahmad et al. reported that BV significantly reduced high blood sugar in diabetic mice, correlating with a notable increase in insulin levels [<xref rid="B45-pharmaceutics-17-00172" ref-type="bibr">45</xref>]. Moreover, BV can significantly lower levels of malondialdehyde, cholesterol, triglycerides, creatinine, and aminotransferases compared to diabetic animals. Fortunately, BV has been found to enhance total antioxidant capacity, glutathione content, and catalase activity. Additionally, BV has shown potential in improving pancreatic function by enhancing the structure of the islets and regenerating &#x003b2; cells responsible for insulin secretion. Khulan et al. reported that BV could lower blood glucose levels while significantly increasing plasma insulin levels [<xref rid="B46-pharmaceutics-17-00172" ref-type="bibr">46</xref>].</p><p>Alpha-glucosidase is comparable to &#x003b1;-amylase as an enzyme that hydrolyzes starch. However, &#x003b1;-amylase hydrolyzes the 1,4-glycosidic bonds in polysaccharides to release disaccharides, while &#x003b1;-glucosidase catalyzes the hydrolysis of disaccharides to monosaccharides, leading to postprandial hyperglycemia. Therefore, the inhibition of alpha-glucosidase activity is considered an antidote for type 2 diabetes. The same concentrations of acarbose, nanofilm, BV, PVA-B, and PVA-BV were evaluated for their &#x003b1;-glucosidase inhibitory activity, with the mean absorbance measured at 540 nm. BV exhibited antidiabetic activity by inhibiting &#x003b1;-glucosidase with an IC<sub>50</sub> of 7.3 &#x003bc;g/mL, compared to the IC<sub>50</sub> of acarbose as a standard &#x003b1;-amylase inhibitor, which is 2.57 &#x003bc;g/mL. However, when BV was loaded onto PVA, it showed lower antidiabetic activity, with an IC<sub>50</sub> of 16.05 &#x003bc;g/mL (<xref rid="pharmaceutics-17-00172-t002" ref-type="table">Table 2</xref>). PVA-B showed very low inhibition of &#x003b1;-glucosidase, with an IC<sub>50</sub> of 736.78 &#x003bc;g/mL, indicating no significant antidiabetic activity. However, nanofilm exhibited the highest antidiabetic activity by inhibiting &#x003b1;-glucosidase, with an IC<sub>50</sub> of 5.55 &#x003bc;g/mL. In the current study, the nanofilm of BV, PVA, and ZNPs effectively inhibits key starch-degrading enzymes (&#x003b1;-amylase and &#x003b1;-glucosidase), indicating a strong potential for managing type 2 diabetes. BV was administered in vivo for the management of diabetes, resulting in a reduction in serum glucose levels, followed by a significant increase in insulin levels compared to the diabetic rats [<xref rid="B47-pharmaceutics-17-00172" ref-type="bibr">47</xref>]. Ryu et al. reported that &#x003b1;-glucosidase is a key enzyme responsible for the breakdown of maltose into glucose for absorption into the bloodstream in the small intestine [<xref rid="B48-pharmaceutics-17-00172" ref-type="bibr">48</xref>]. Consequently, &#x003b1;-glucosidase inhibitors are considered an antidote for type 2 diabetes, as they help regulate the abnormal rise in plasma blood sugar after eating. Zhang et al. noted that although acarbose, voglibose, and miglitol are effective &#x003b1;-glucosidase inhibitors and approved antidotes for type 2 diabetes, they have adverse effects, such as abdominal cramping, flatulence, and diarrhea [<xref rid="B49-pharmaceutics-17-00172" ref-type="bibr">49</xref>]. Therefore, natural products with therapeutic properties, such as bee products, are essential for use as nutraceuticals and antidiabetics. BV and propolis are versatile natural therapeutic products that exhibit various therapeutic activities, including antioxidant, anti-inflammatory, anticancer, antiviral, antibacterial, antifungal, and antidiabetic properties.</p></sec><sec id="sec3dot4-pharmaceutics-17-00172"><title>3.4. Augmented Anti-Inflammatory Activity of PVA-Treated Bee Venom: Mechanistic Insights into RBC Hemolysis Inhibition and DAMP Suppression</title><p>Red blood cell (RBC) breakdown results in the release of large amounts of inflammatory substances known as damage-associated molecular patterns (DAMPs), which enter the bloodstream and cause inflammation. Therefore, inhibiting RBC hemolysis prevents inflammation by stopping the release of DAMPs. Bee venom (BV) showed anti-inflammatory activity with an IC<sub>50</sub> of 72.99 &#x003bc;g/mL, which decreased to 22.12 &#x003bc;g/mL with PVA-treated BV (PVA-BV), indicating higher anti-inflammatory activity of the latter compared to standard indomethacin, which has an IC<sub>50</sub> of 5.86 &#x003bc;g/mL (<xref rid="pharmaceutics-17-00172-t003" ref-type="table">Table 3</xref>). PVA-B demonstrated minimal anti-inflammatory activity, with an IC<sub>50</sub> of 41.27 &#x003bc;g/mL. In contrast, nanofilm exhibited the highest anti-inflammatory activity, with an IC<sub>50</sub> of 16.99 &#x003bc;g/mL.</p><p>The same concentrations of indomethacin, BV, PVA-BV, PVA-B, and nanofilm were examined for their inhibition of RBC hemolysis, with mean absorbance measured at 540 nm. The nanofilm demonstrated the highest inhibition of RBC hemolysis (98.7%) at 1000 &#x003bc;g/mL (<xref rid="pharmaceutics-17-00172-f005" ref-type="fig">Figure 5</xref>a), compared to indomethacin (99.4%), followed by PVA-BV (95.1%) (<xref rid="pharmaceutics-17-00172-f005" ref-type="fig">Figure 5</xref>b), PVA-B (93.1%) (<xref rid="pharmaceutics-17-00172-f005" ref-type="fig">Figure 5</xref>c), and BV (88.2%) (<xref rid="pharmaceutics-17-00172-f005" ref-type="fig">Figure 5</xref>d). In the present study, nanofilm inhibited red blood cell hemolysis, showcasing its anti-inflammatory effects.</p><p>Bellik reported that BV exerts an anti-inflammatory response by decreasing the expression of COX-2, PLA2, TNF-&#x003b1;, IL-1, IL-6, and NO, as well as reducing intracellular calcium levels [<xref rid="B50-pharmaceutics-17-00172" ref-type="bibr">50</xref>]. Although BV is a mixture of many substances, melittin, adolapin, and tertiapin are primarily responsible for its anti-inflammatory effects. Both melittin and adolapin inhibit prostaglandin synthesis, thereby reducing the activities of cyclooxygenase and lipoxygenase. Dadar et al. found that tertiapin exhibits anti-inflammatory activity by blocking potassium channels [<xref rid="B51-pharmaceutics-17-00172" ref-type="bibr">51</xref>].</p></sec><sec id="sec3dot5-pharmaceutics-17-00172"><title>3.5. Potent Antimicrobial Efficacy of Bee Venom, PVA-BV, and Nanofilm Against Diverse Bacterial and Fungal Strains</title><p>BV is an important active compound extracted from <italic toggle="yes">Apis mellifera</italic> L. (honeybee) that has antimicrobial activity, particularly against bacteria (both Gram-positive and Gram-negative) and fungi. Therefore, BV is considered a natural broad-spectrum antibiotic with minimal side effects. BV, PVA-BV, PVA-B, and nanofilm were tested for antibacterial activity in comparison to gentamicin (50 &#x000b5;g/mL) as a positive control, and for antifungal activity compared to fluconazole (32 &#x000b5;g/mL) as another positive control (<xref rid="pharmaceutics-17-00172-t004" ref-type="table">Table 4</xref>). PVA-B did not demonstrate any antimicrobial activity, while nanofilm displayed the highest antimicrobial activity, except against <italic toggle="yes">B. subtilis</italic> ATCC 6633, where the nanofilm was found to have the same activity as PVA-BV and the control (<xref rid="pharmaceutics-17-00172-f006" ref-type="fig">Figure 6</xref>a). <italic toggle="yes">S. aureus</italic> ATCC 6538 was most susceptible to the nanofilm, followed by BV, PVA-BV, and control (<xref rid="pharmaceutics-17-00172-f006" ref-type="fig">Figure 6</xref>b). <italic toggle="yes">E. coli</italic> ATCC 8739 also showed the highest susceptibility to the nanofilm, followed by BV, PVA-BV, and the control (<xref rid="pharmaceutics-17-00172-f006" ref-type="fig">Figure 6</xref>c). <italic toggle="yes">S. typhi</italic> ATCC 6539 was most susceptible to the nanofilm; however, the effects of BV, PVA-BV, and the control were similar (<xref rid="pharmaceutics-17-00172-f006" ref-type="fig">Figure 6</xref>d). <italic toggle="yes">C. albicans</italic> ATCC 10221 exhibited the greatest susceptibility to the nanofilm and control, followed by BV and PVA-BV (<xref rid="pharmaceutics-17-00172-f006" ref-type="fig">Figure 6</xref>e). <italic toggle="yes">A. brasiliensi</italic> (formerly known as <italic toggle="yes">A. niger</italic>) ATCC 16888 was most susceptible to the control, followed by nanofilm, whereas BV and PVA-BV showed no activity (<xref rid="pharmaceutics-17-00172-f006" ref-type="fig">Figure 6</xref>f). This study showed that nanofilm exhibited broad-spectrum antibiotic activity against Gram-positive and Gram-negative bacteria, as well as molds like <italic toggle="yes">Candida albicans</italic> and <italic toggle="yes">Aspergillus brasiliensis</italic>. Haitham et al. reported that BV and its nanofilm (BV-V1, Carnica bee-V2, New Zealand type-V5) exhibited antibacterial activity against dental pathogens, including <italic toggle="yes">Streptococcus</italic> sp., <italic toggle="yes">Enterococcus</italic> sp., and <italic toggle="yes">Bacillus</italic> sp. at 50 &#x000b5;g/mL [<xref rid="B52-pharmaceutics-17-00172" ref-type="bibr">52</xref>]. In addition to that, El-Sayied et al. (2024) reported that combining BV with nanoparticles significantly enhanced antibacterial efficacy against <italic toggle="yes">Paenibacillus larvae</italic> [<xref rid="B53-pharmaceutics-17-00172" ref-type="bibr">53</xref>]. Barnes et al. documented that kanamycin, chloramphenicol, and streptomycin, as standard antibiotics, inhibited the growth of two <italic toggle="yes">Streptococcus</italic> isolates (<italic toggle="yes">S. mutans</italic> and <italic toggle="yes">S. sanguinis</italic>), while the five types of BV inhibited all <italic toggle="yes">Streptococcus</italic> isolates at concentrations of 30, 40, and 50 &#x000b5;g/mL [<xref rid="B54-pharmaceutics-17-00172" ref-type="bibr">54</xref>]. Additionally, BV demonstrated antibacterial activity against <italic toggle="yes">Enterococcus</italic> sp. and <italic toggle="yes">E. faecalis</italic>. Hegazi et al. demonstrated that Gram-positive bacteria (both coagulase-positive and coagulase-negative <italic toggle="yes">Staphylococcus</italic>) were more sensitive to BV at lower concentrations than Gram-negative bacteria, such as <italic toggle="yes">E. coli</italic>, <italic toggle="yes">Salmonella</italic>, <italic toggle="yes">E. cloacae</italic>, and <italic toggle="yes">Citrobacter freundii</italic> [<xref rid="B55-pharmaceutics-17-00172" ref-type="bibr">55</xref>].</p><p>The MIC and MBC in &#x000b5;g/mL were determined for BV, PVA-BV, and nanofilm against <italic toggle="yes">B. subtilis</italic> ATCC 6633, <italic toggle="yes">S. aureus</italic> ATCC 6538, <italic toggle="yes">E. coli</italic> ATCC 8739, <italic toggle="yes">S. typhi</italic> ATCC 6539, and <italic toggle="yes">C. albicans</italic> ATCC 10221 (<xref rid="pharmaceutics-17-00172-t005" ref-type="table">Table 5</xref>). In <italic toggle="yes">B. subtilis</italic> ATCC 6633, the MICs of BV, PVA-BV, and nanofilm were similar, while the MBC of PVA-BV was higher than that of the homologous nanofilm and BV. In <italic toggle="yes">S. aureus</italic> ATCC 6538, the MIC of nanofilm was the lowest, followed by the MICs of BV and PVA-BV. The MBCs of nanofilm and BV were the same and higher than those of PVA-BV. In <italic toggle="yes">E. coli</italic> ATCC 8739, the MICs of nanofilm and BV were the same and lower than that of PVA-BV; similarly, the MBCs of nanofilm and BV were the same and lower than that of PVA-BV. In <italic toggle="yes">S. typhi</italic> ATCC 6539, the MIC of nanofilm was the lowest, followed by those of BV and PVA-BV, and the MBC of nanofilm was also the lowest, followed by BV and PVA-BV. In <italic toggle="yes">C. albicans</italic> ATCC 10221, the MIC of nanofilm was the lowest, followed by BV and PVA-BV, and the MBC of nanofilm was also the lowest, followed by BV and PVA-BV. Therefore, Gram-negative bacteria, especially <italic toggle="yes">S. typhi</italic> ATCC 6539, were more resistant to BV, PVA-BV, and nanofilm than Gram-positive bacteria and <italic toggle="yes">C. albicans</italic> ATCC 10221. Moreover, the nanofilm was a more effective antimicrobial agent than BV and PVA-BV. Haitham et al. [<xref rid="B51-pharmaceutics-17-00172" ref-type="bibr">51</xref>] reported that the MICs of the nanofilm of BV were 31.31 &#x000b5;g/mL for <italic toggle="yes">Enterococcus faecium</italic>, 39.81 &#x000b5;g/mL for <italic toggle="yes">Staphylococcus sciuri</italic>, and 44.39 &#x000b5;g/mL for <italic toggle="yes">Streptococcus mitis</italic>, while the MBC for all three strains was almost the same (30 &#x000b5;g/mL). The MIC and MBC results demonstrated the efficacy of nanofilm against the tested microorganisms, with values of &#x02264;31.25 &#x000b5;g/mL and 62.50 &#x000b5;g/mL, respectively.</p></sec><sec id="sec3dot6-pharmaceutics-17-00172"><title>3.6. Noteworthy Antioxidant Potency of Bee Venom (BV) and Nanofilm Demonstrated Through DPPH Radical Scavenging Assays</title><p>Antioxidant activity is assessed by the inhibition of lipid peroxidation, thus scavenging DPPH free radicals. The same concentrations of standard ascorbic acid, nanofilm, BV, PVA-B, and PVA-BV were tested for their DPPH scavenging effect, with the mean absorbance measured at 517 nm. BV showed antioxidant activity by scavenging DPPH with an IC<sub>50</sub> of 19.43 &#x003bc;g/mL, compared to the IC<sub>50</sub> of standard ascorbic acid, which is 2.35 &#x003bc;g/mL. PVA-BV exhibited higher antioxidant activity than BV, with an IC<sub>50</sub> of 5.84 &#x003bc;g/mL (<xref rid="pharmaceutics-17-00172-t006" ref-type="table">Table 6</xref>). PVA-B showed very low antioxidant activity that could be neglected, with an IC<sub>50</sub> of 818.41 &#x000b5;g/mL. However, the nanofilm demonstrated the highest antioxidant activity, with an IC<sub>50</sub> of 4.26 &#x003bc;g/mL. Somwongin et al. demonstrated that BV collected from European <italic toggle="yes">A. mellifera</italic> was found to have therapeutic effects, including antioxidant activity, due to its high capacity to scavenge DPPH [<xref rid="B56-pharmaceutics-17-00172" ref-type="bibr">56</xref>]. Melittin, which is the largest component in the BV formulation (76.5 &#x000b1; 1.9%), showed the highest inhibition of lipid peroxidation and DPPH removal. BV extracted from <italic toggle="yes">A. mellifera</italic>, especially melittin, demonstrated severe irritation (13.7 &#x000b1; 0.5 at 2 mg/mL). Elswaby et al. reported that ethanolic extracts of BV samples collected from Kafr El-Sheikh, Fayoum, and Giza governorates were tested to determine that propolis was a more effective antioxidant than BV [<xref rid="B57-pharmaceutics-17-00172" ref-type="bibr">57</xref>]. The antioxidant activities of BV and propolis extracted with ethanol, chloroform, and water were assessed using the DPPH method, with ascorbic acid as a control. The extracts exhibited different levels of free radical scavenging effect. More DPPH radicals were removed by BV than by propolis. Ethanolic extracts were found to be more effective in generating potent antioxidants. Ethanolic extracts of propolis collected from the Kafr El-Sheikh or Fayoum governorates at a concentration of 0.2 mg/mL demonstrated the highest free radical scavenging effects, achieving 94.0 &#x000b1; 1.5% and 93.7 &#x000b1; 1.8%, respectively, with no significant difference between the two regions. In contrast, the antioxidant properties of chloroform and water extracts of BV collected from the Giza governorate at identical concentrations were comparable and the lowest, showing 44.0 &#x000b1; 1.5% and 43.0 &#x000b1; 1.2%, respectively, with no significant difference between the two types of extracts. All extracts inhibited DPPH radical production in a dose-dependent manner, with efficacy increasing with concentration. At a high concentration (0.2 mg/mL), the antioxidant activities of the ethanolic extracts of propolis collected from Kafr El-Sheikh and Fayoum governorates were statistically like those of ascorbic acid, a powerful antioxidant used as a control. Rivero-Cruz et al. showed that the modern approach in the pharmaceutical industry involves using natural products, including bee products, especially BV and propolis, because of their therapeutic effects, including antioxidant properties [<xref rid="B58-pharmaceutics-17-00172" ref-type="bibr">58</xref>]. The therapeutic effects of BV and propolis are attributed to several biologically active compounds, such as phenols and flavonoids in propolis, and melittin in BV. The antioxidants found in nanofilm and BV in this study will aid in the development of synthetic antioxidant compounds.</p></sec><sec id="sec3dot7-pharmaceutics-17-00172"><title>3.7. Promising Cytotoxicity of Bee Venom and Nanofilm Against HepG2 Cancer Cell Line</title><p>BV and nanofilm were tested for their effects (viability and toxicity) on the HepG2 cell line (liver tissue). The normal cell line did not show any abnormal manifestations, such as shrinkage or swelling (<xref rid="pharmaceutics-17-00172-f007" ref-type="fig">Figure 7</xref>a). Different concentrations of BV (<xref rid="pharmaceutics-17-00172-f007" ref-type="fig">Figure 7</xref>b) and nanofilm (<xref rid="pharmaceutics-17-00172-f007" ref-type="fig">Figure 7</xref>c) were tested for their effects on the cell line (<xref rid="pharmaceutics-17-00172-t007" ref-type="table">Table 7</xref>). BV was more toxic to liver tissue (HepG2 cell line) than nanofilm, with an IC<sub>50</sub> of 18.5 &#x000b1; 0.08 &#x003bc;g/mL (<xref rid="pharmaceutics-17-00172-f008" ref-type="fig">Figure 8</xref>a) and 52.27 &#x000b1; 0.7 &#x003bc;g/mL (<xref rid="pharmaceutics-17-00172-f008" ref-type="fig">Figure 8</xref>b), respectively. The BV extract showed higher toxicity to liver tissue (2.3%) with 97.7% viability at 250 &#x003bc;g/mL compared to the nanofilm, which showed 0.09% toxicity and 99.9% viability at the same concentration, demonstrating its potential for safer clinical applications. Although toxicity decreased and viability increased with decreasing concentrations of BV and nanofilm, the nanofilm was less toxic and more viable than BV. In comparison to our study, BV demonstrated an IC<sub>50</sub> of 93.21 &#x003bc;g/mL against HepG2 cells [<xref rid="B59-pharmaceutics-17-00172" ref-type="bibr">59</xref>]. Additionally, Kamel et al. (2024) reported that chitosan nanoparticles loaded with BV exhibited cytotoxicity against MCF-7 cells (IC<sub>50</sub> of 437.2 &#x003bc;g/mL) and HepG2 cells (IC<sub>50</sub> of 109.5 &#x003bc;g/mL) through the induction of ROS generation [<xref rid="B60-pharmaceutics-17-00172" ref-type="bibr">60</xref>]. Furthermore, the anticancer potential of BV is attributed to its melittin content, which acts as an anticancer agent [<xref rid="B61-pharmaceutics-17-00172" ref-type="bibr">61</xref>]. Young et al. reported that BV has various therapeutic activities, including anti-inflammatory, antimicrobial, antioxidant, and anticancer effects [<xref rid="B62-pharmaceutics-17-00172" ref-type="bibr">62</xref>]. The toxicity of BV was investigated on normal human lymphocytes and HL-60 cells. Cells treated with BV at concentrations of 1 or 5 &#x003bc;g/mL were found to die within 24 h. However, when treated with BV at a concentration of 10 &#x003bc;g/mL, cell viability decreased over 72 h, potentially due to the half-life of BV. BV also completely inhibited the proliferation of these cells. Additionally, BV induced DNA fragmentation and micronuclei formation in HL-60 cells, and DNA fragmentation in human lymphocytes. The elevated levels of phosphatase and tensin homolog (PTEN) in HL-60 cells may arrest the cell cycle in the S phase. Upregulation of the forkhead transcription factors (FKHR and FKHRL1) in human lymphocytes after complete BV treatment may play a role in DNA damage repair and reducing genotoxicity. This suggests that BV may exert cytotoxic effects on these two cell types through different mechanisms. Finally, the anticancer experiment in the present study confirmed the potential of BV as an anticancer agent. However, further research is needed to evaluate the application of BV on a broader range of cancer cell lines to fully document and validate our results.</p></sec><sec id="sec3dot8-pharmaceutics-17-00172"><title>3.8. Comprehensive Profiling of Bioactive Compounds in Bee Venom via Mass Spectrometry (MS)</title><p>The BV extract was analyzed using MS as a specialized microanalysis technique to determine the type and concentration of its components. The BV extract was found to consist of 84 active components (<xref rid="pharmaceutics-17-00172-t008" ref-type="table">Table 8</xref>) at various concentrations. The active components were identified by MS, where some were observed to repeat at different retention times, peak heights, and areas (<xref rid="pharmaceutics-17-00172-f009" ref-type="fig">Figure 9</xref>). Sharma and Rana found that the BV extract was analyzed into 41 individual compounds, which included hydrocarbons, alcohols, ketones, carboxylic acids, steroids, esters, retinoids, phenols, terpenes, amines, and others [<xref rid="B63-pharmaceutics-17-00172" ref-type="bibr">63</xref>]. According to Jadhav et al. (2024), the liquid chromatography&#x02013;mass spectrometry (LC-MS) analysis of BV nanoparticles revealed the presence of 23 bioactive compounds, among which melittin and apamin play significant roles in pharmacological applications [<xref rid="B61-pharmaceutics-17-00172" ref-type="bibr">61</xref>]. The compounds with a retention time of 5.14&#x02014;namely, &#x003b1;-Phellandrene, Bicyclo [3.1.0] Hexane, 4-methylene-1-(1-methylethyl)-, and &#x003b1;-Pinene&#x02014;acquired the highest peak area, constituting 24.29% of the total peak area. Thangaleela et al. reported that terpenes, including phellandrene, pinene, terpinyl acetate, and andrographolide, recorded the highest peaks during the MS analysis of the BV extract and are known to possess biopharmacological activities [<xref rid="B64-pharmaceutics-17-00172" ref-type="bibr">64</xref>]. Our analysis revealed several promising compounds that are suitable for a variety of pharmacological applications.</p></sec></sec><sec sec-type="conclusions" id="sec4-pharmaceutics-17-00172"><title>4. Conclusions</title><p>The growing trend toward sustainable treatments has driven significant advancements, particularly with the development of disposable films that enable continuous therapeutic release. In this study, a disposable, multifunctional, and biocompatible nanofilm was successfully developed, comprising PVA complexed with BV. The bee venom serves as both a stabilizer and a reducing agent, facilitating the conversion of bulk zinc to ZNPs. The structural properties of the nanofilm were characterized through physicochemical analyses, confirming the successful integration of PVA, BV, and ZNPs. Topographical investigations using FE-SEM and HR-TEM demonstrated a uniform distribution of ZNPs throughout the nanofilm. The nanofilm demonstrated effective inhibition of various pathogenic bacteria, with variable levels of activity. Furthermore, it displayed strong antioxidant properties (IC<sub>50</sub> 4.26 &#x003bc;g/mL), surpassing BV (IC<sub>50</sub> 19.43 &#x003bc;g/mL) in the DPPH assay. Interestingly, BV exhibited superior anticancer activity (IC<sub>50</sub> 18.5 &#x000b1; 0.08 &#x003bc;g/mL) compared to the nanofilm (IC<sub>50</sub> 52.27 &#x000b1; 0.7 &#x003bc;g/mL) against the HepG2 cell line. The BV-based nanofilm exhibited notable therapeutic potential, functioning as an antidote against hyperglycemia, inflammation, microbial proliferation, and oxidative stress induced by free radicals, all while showing no cytotoxic effects on liver cell lines. These findings highlight its potential as a next-generation biocompatible nanomaterial for managing chronic conditions, such as diabetes, inflammation, and microbial infections. The substantial content of therapeutically active compounds, combined with an efficient delivery mechanism, positions the BV nanofilm as a promising alternative therapeutic agent for a wide range of diseases.</p></sec></body><back><ack><title>Acknowledgments</title><p>All authors thank the Scientific Research Deanship at University of Ha&#x02019;il for their grant through project number RG-24 037. The graphical abstract was created with <uri>BioRender.com</uri>.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, H.Q.; formal analysis&#x02014;antimicrobial activity, A.S.B., S.F.A. and H.B.; formal analysis&#x02014;anticancer activity, H.Q. and S.F.A.; formal analysis&#x02014;antihemolytic and anti-inflammatory activities, N.K.B. and M.N.A.; formal analysis&#x02014;antioxidant activity, B.A.; formal analysis&#x02014;antidiabetic activity, A.A.; investigation, H.Q., A.S.B., S.F.A., N.K.B., H.B., B.A., A.A. and M.N.A.; visualization and validation, H.Q., A.S.B., S.F.A., N.K.B., H.B., B.A., A.A. and M.N.A.; supervision, H.Q.; funding acquisition, H.Q.; writing&#x02014;original draft preparation, H.Q., A.S.B. and S.F.A.; writing&#x02014;review and editing; H.Q., A.S.B., S.F.A., N.K.B., H.B., B.A., A.A. and M.N.A. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The study was approved by the Ethics Committee at the University of Ha&#x02019;il (Reference H-2023-380, approval date: 16 October 2023). Patient privacy and confidentiality of data were maintained in accordance with The Declaration of Helsinki.</p></notes><notes><title>Informed Consent Statement</title><p>Informed consent was obtained from all subjects involved in the study.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data that supports the findings of this study are available within the article and from the corresponding author upon request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-pharmaceutics-17-00172"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Silva</surname><given-names>J.</given-names></name>
<name><surname>Monge-Fuentes</surname><given-names>V.</given-names></name>
<name><surname>Gomes</surname><given-names>F.</given-names></name>
<name><surname>Lopes</surname><given-names>K.</given-names></name>
<name><surname>dos Anjos</surname><given-names>L.</given-names></name>
<name><surname>Campos</surname><given-names>G.</given-names></name>
<name><surname>Arenas</surname><given-names>C.</given-names></name>
<name><surname>Biolchi</surname><given-names>A.</given-names></name>
<name><surname>Gon&#x000e7;alves</surname><given-names>J.</given-names></name>
<name><surname>Galante</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools</article-title><source>Toxins</source><year>2015</year><volume>7</volume><fpage>3179</fpage><lpage>3209</lpage><pub-id pub-id-type="doi">10.3390/toxins7083179</pub-id><pub-id pub-id-type="pmid">26295258</pub-id>
</element-citation></ref><ref id="B2-pharmaceutics-17-00172"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Santos</surname><given-names>L.</given-names></name>
<name><surname>Pieroni</surname><given-names>M.</given-names></name>
<name><surname>Menegasso</surname><given-names>A.R.S.</given-names></name>
<name><surname>Pinto</surname><given-names>J.</given-names></name>
<name><surname>Palma</surname><given-names>M.</given-names></name>
</person-group><article-title>A new scenario of bioprospecting of Hymenoptera venoms through proteomic approach</article-title><source>J. Venom. Anim. Toxins Incl. Trop. Dis.</source><year>2010</year><volume>17</volume><fpage>364</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1590/S1678-91992011000300004</pub-id></element-citation></ref><ref id="B3-pharmaceutics-17-00172"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Chen</surname><given-names>T.</given-names></name>
<name><surname>Zhang</surname><given-names>N.</given-names></name>
<name><surname>Yang</surname><given-names>M.</given-names></name>
<name><surname>Li</surname><given-names>B.</given-names></name>
<name><surname>L&#x000fc;</surname><given-names>X.</given-names></name>
<name><surname>Cao</surname><given-names>X.</given-names></name>
<name><surname>Ling</surname><given-names>C.</given-names></name>
</person-group><article-title>Melittin, a Major Component of Bee Venom, Sensitizes Human Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Activating CaMKII-TAK1-JNK/p38 and Inhibiting I&#x003ba;B&#x003b1; Kinase-NF&#x003ba;B*</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>3804</fpage><lpage>3813</lpage><pub-id pub-id-type="doi">10.1074/jbc.M807191200</pub-id><pub-id pub-id-type="pmid">19074436</pub-id>
</element-citation></ref><ref id="B4-pharmaceutics-17-00172"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ali</surname><given-names>M.</given-names></name>
</person-group><article-title>Studies on Bee Venom and Its Medical Uses</article-title><source>Int. J. Adv. Res. Technol.</source><year>2012</year><volume>1</volume><fpage>69</fpage><lpage>83</lpage></element-citation></ref><ref id="B5-pharmaceutics-17-00172"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H.J.</given-names></name>
<name><surname>Jeon</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Is acupuncture efficacious therapy in Parkinson&#x02019;s disease?</article-title><source>J. Neurol. Sci.</source><year>2014</year><volume>341</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2014.04.016</pub-id><pub-id pub-id-type="pmid">24798223</pub-id>
</element-citation></ref><ref id="B6-pharmaceutics-17-00172"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>J.H.</given-names></name>
<name><surname>Kim</surname><given-names>K.H.</given-names></name>
<name><surname>Kim</surname><given-names>S.J.</given-names></name>
<name><surname>Lee</surname><given-names>W.R.</given-names></name>
<name><surname>Lee</surname><given-names>K.G.</given-names></name>
<name><surname>Park</surname><given-names>K.K.</given-names></name>
</person-group><article-title>Bee venom protects hepatocytes from tumor necrosis factor-alpha and actinomycin D</article-title><source>Arch. Pharm. Res.</source><year>2010</year><volume>33</volume><fpage>215</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1007/s12272-010-0205-6</pub-id><pub-id pub-id-type="pmid">20195821</pub-id>
</element-citation></ref><ref id="B7-pharmaceutics-17-00172"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bogdanov</surname><given-names>S.</given-names></name>
</person-group><article-title>Bee venom: Composition, health, medicine: A review</article-title><source>Bee Product Sci.</source><year>2012</year><fpage>1</fpage><lpage>20</lpage></element-citation></ref><ref id="B8-pharmaceutics-17-00172"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Song</surname><given-names>B.</given-names></name>
<name><surname>Cho</surname><given-names>C.-W.</given-names></name>
</person-group><article-title>Applying polyvinyl alcohol to the preparation of various nanoparticles</article-title><source>J. Pharm. Investig.</source><year>2024</year><volume>54</volume><fpage>249</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1007/s40005-023-00649-4</pub-id></element-citation></ref><ref id="B9-pharmaceutics-17-00172"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jayakrishnan</surname><given-names>P.</given-names></name>
<name><surname>Ramesan</surname><given-names>M.T.</given-names></name>
</person-group><article-title>Synthesis, Characterization, Electrical Conductivity and Material Properties of Magnetite/Polyindole/Poly(vinyl alcohol) Blend Nanocomposites</article-title><source>J. Inorg. Organomet. Polym. Mater.</source><year>2017</year><volume>27</volume><fpage>323</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1007/s10904-016-0474-8</pub-id></element-citation></ref><ref id="B10-pharmaceutics-17-00172"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Higazy</surname><given-names>I.M.</given-names></name>
<name><surname>Mahmoud</surname><given-names>A.A.</given-names></name>
<name><surname>Ghorab</surname><given-names>M.M.</given-names></name>
<name><surname>Ammar</surname><given-names>H.O.</given-names></name>
</person-group><article-title>Development and evaluation of polyvinyl alcohol stabilized polylactide-co-caprolactone-based nanoparticles for brain delivery</article-title><source>J. Drug Deliv. Sci. Technol.</source><year>2021</year><volume>61</volume><fpage>102274</fpage><pub-id pub-id-type="doi">10.1016/j.jddst.2020.102274</pub-id></element-citation></ref><ref id="B11-pharmaceutics-17-00172"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>H.</given-names></name>
<name><surname>Yang</surname><given-names>H.</given-names></name>
<name><surname>Fang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>K.</given-names></name>
<name><surname>Tian</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Tan</surname><given-names>Y.</given-names></name>
<name><surname>Lai</surname><given-names>W.</given-names></name>
<name><surname>Bian</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Neurotoxicity and biomarkers of zinc oxide nanoparticles in main functional brain regions and dopaminergic neurons</article-title><source>Sci. Total Environ.</source><year>2020</year><volume>705</volume><fpage>135809</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2019.135809</pub-id><pub-id pub-id-type="pmid">31829301</pub-id>
</element-citation></ref><ref id="B12-pharmaceutics-17-00172"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mahfouz</surname><given-names>H.</given-names></name>
<name><surname>Dahran</surname><given-names>N.</given-names></name>
<name><surname>Abdel-Rahman Mohamed</surname><given-names>A.</given-names></name>
<name><surname>Abd El-Hakim</surname><given-names>Y.M.</given-names></name>
<name><surname>Metwally</surname><given-names>M.M.M.</given-names></name>
<name><surname>Alqahtani</surname><given-names>L.S.</given-names></name>
<name><surname>Abdelmawlla</surname><given-names>H.A.</given-names></name>
<name><surname>Wahab</surname><given-names>H.A.</given-names></name>
<name><surname>Shamlan</surname><given-names>G.</given-names></name>
<name><surname>Nassan</surname><given-names>M.A.</given-names></name>
<etal/>
</person-group><article-title>Stabilization of glutathione redox dynamics and CYP2E1 by green synthesized Moringa oleifera-mediated zinc oxide nanoparticles against acrylamide induced hepatotoxicity in rat model: Morphometric and molecular perspectives</article-title><source>Food Chem. Toxicol.</source><year>2023</year><volume>176</volume><fpage>113744</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2023.113744</pub-id><pub-id pub-id-type="pmid">36965644</pub-id>
</element-citation></ref><ref id="B13-pharmaceutics-17-00172"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dahran</surname><given-names>N.</given-names></name>
<name><surname>Abd-Elhakim</surname><given-names>Y.M.</given-names></name>
<name><surname>Mohamed</surname><given-names>A.A.</given-names></name>
<name><surname>Abd-Elsalam</surname><given-names>M.M.</given-names></name>
<name><surname>Said</surname><given-names>E.N.</given-names></name>
<name><surname>Metwally</surname><given-names>M.M.M.</given-names></name>
<name><surname>Abdelhamid</surname><given-names>A.E.</given-names></name>
<name><surname>Hassan</surname><given-names>B.A.</given-names></name>
<name><surname>Alsieni</surname><given-names>M.</given-names></name>
<name><surname>Alosaimi</surname><given-names>M.E.</given-names></name>
<etal/>
</person-group><article-title>Palliative effect of Moringa olifera-mediated zinc oxide nanoparticles against acrylamide-induced neurotoxicity in rats</article-title><source>Food Chem. Toxicol.</source><year>2023</year><volume>171</volume><fpage>113537</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2022.113537</pub-id><pub-id pub-id-type="pmid">36442736</pub-id>
</element-citation></ref><ref id="B14-pharmaceutics-17-00172"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abdallah</surname><given-names>E.A.</given-names></name>
</person-group><article-title>A Study of Sub-Chronic Genotoxic Effects of Zinc Oxide Nanoparticles &#x00026; Protective Role of Vitamin E on the Stomach and Pancreas in Adult Albino Rats</article-title><source>Egypt. J. Forensic Sci. Appl. Toxicol.</source><year>2018</year><volume>18</volume><fpage>25</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.21608/ejfsat.2018.4194.1017</pub-id></element-citation></ref><ref id="B15-pharmaceutics-17-00172"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Senapati</surname><given-names>V.A.</given-names></name>
<name><surname>Gupta</surname><given-names>G.S.</given-names></name>
<name><surname>Pandey</surname><given-names>A.K.</given-names></name>
<name><surname>Shanker</surname><given-names>R.</given-names></name>
<name><surname>Dhawan</surname><given-names>A.</given-names></name>
<name><surname>Kumar</surname><given-names>A.</given-names></name>
</person-group><article-title>Zinc oxide nanoparticle induced age dependent immunotoxicity in BALB/c mice</article-title><source>Toxicol. Res.</source><year>2017</year><volume>6</volume><fpage>342</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1039/C6TX00439C</pub-id><pub-id pub-id-type="pmid">30090503</pub-id>
</element-citation></ref><ref id="B16-pharmaceutics-17-00172"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eleiwa</surname><given-names>N.Z.H.</given-names></name>
<name><surname>Ali</surname><given-names>M.A.</given-names></name>
<name><surname>Said</surname><given-names>E.N.</given-names></name>
<name><surname>Metwally</surname><given-names>M.M.M.</given-names></name>
<name><surname>Abd-ElHakim</surname><given-names>Y.M.</given-names></name>
</person-group><article-title>Bee venom (<italic toggle="yes">Apis mellifera</italic> L.) rescues zinc oxide nanoparticles induced neurobehavioral and neurotoxic impact via controlling neurofilament and GAP-43 in rat brain</article-title><source>Environ. Sci. Pollut. Res. Int.</source><year>2023</year><volume>30</volume><fpage>88685</fpage><lpage>88703</lpage><pub-id pub-id-type="doi">10.1007/s11356-023-28538-1</pub-id><pub-id pub-id-type="pmid">37442924</pub-id>
</element-citation></ref><ref id="B17-pharmaceutics-17-00172"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shafiee</surname><given-names>P.</given-names></name>
<name><surname>Reisi Nafchi</surname><given-names>M.</given-names></name>
<name><surname>Eskandarinezhad</surname><given-names>S.</given-names></name>
<name><surname>Mahmoudi</surname><given-names>S.</given-names></name>
<name><surname>Ahmadi</surname><given-names>E.</given-names></name>
</person-group><article-title>Sol-gel zinc oxide nanoparticles: Advances in synthesis and applications</article-title><source>Synth. Sinter.</source><year>2021</year><volume>1</volume><fpage>242</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.53063/synsint.2021.1477</pub-id></element-citation></ref><ref id="B18-pharmaceutics-17-00172"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hashem</surname><given-names>A.H.</given-names></name>
<name><surname>El-Naggar</surname><given-names>M.E.</given-names></name>
<name><surname>Abdelaziz</surname><given-names>A.M.</given-names></name>
<name><surname>Abdelbary</surname><given-names>S.</given-names></name>
<name><surname>Hassan</surname><given-names>Y.R.</given-names></name>
<name><surname>Hasanin</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Bio-based antimicrobial food packaging films based on hydroxypropyl starch/polyvinyl alcohol loaded with the biosynthesized zinc oxide nanoparticles</article-title><source>Int. J. Biol. Macromol.</source><year>2023</year><volume>249</volume><elocation-id>126011</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.126011</pub-id><pub-id pub-id-type="pmid">37517763</pub-id>
</element-citation></ref><ref id="B19-pharmaceutics-17-00172"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hasanin</surname><given-names>M.</given-names></name>
<name><surname>Abdel Kader</surname><given-names>A.H.</given-names></name>
<name><surname>Abd El-Sayed</surname><given-names>E.S.</given-names></name>
<name><surname>Kamel</surname><given-names>S.</given-names></name>
</person-group><article-title>Green Chitosan-Flaxseed Gum Film Loaded with ZnO for Packaging Applications</article-title><source>Starch-St&#x000e4;rke</source><year>2023</year><volume>75</volume><fpage>2200132</fpage><pub-id pub-id-type="doi">10.1002/star.202200132</pub-id></element-citation></ref><ref id="B20-pharmaceutics-17-00172"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>R.</given-names></name>
<name><surname>Bisen</surname><given-names>D.P.</given-names></name>
<name><surname>Shukla</surname><given-names>U.</given-names></name>
<name><surname>Sharma</surname><given-names>B.</given-names></name>
</person-group><article-title>X-ray diffraction: A powerful method of characterizing nanomaterials</article-title><source>Recent Res. Sci. Technol.</source><year>2012</year><volume>4</volume><fpage>77</fpage><lpage>79</lpage></element-citation></ref><ref id="B21-pharmaceutics-17-00172"><label>21.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Eid</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Characterization of Nanoparticles by FTIR and FTIR-Microscopy</article-title><source>Handbook of Consumer Nanoproducts</source><publisher-name>Springer Nature</publisher-name><publisher-loc>Singapore</publisher-loc><year>2022</year><fpage>645</fpage><lpage>673</lpage></element-citation></ref><ref id="B22-pharmaceutics-17-00172"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malatesta</surname><given-names>M.</given-names></name>
</person-group><article-title>Transmission Electron Microscopy as a Powerful Tool to Investigate the Interaction of Nanoparticles with Subcellular Structures</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>12789</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222312789</pub-id><pub-id pub-id-type="pmid">34884592</pub-id>
</element-citation></ref><ref id="B23-pharmaceutics-17-00172"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>L&#x000f3;pez Guti&#x000e9;rrez</surname><given-names>J.D.</given-names></name>
<name><surname>Abundez Barrera</surname><given-names>I.M.</given-names></name>
<name><surname>Torres G&#x000f3;mez</surname><given-names>N.</given-names></name>
</person-group><article-title>Nanoparticle Detection on SEM Images Using a Neural Network and Semi-Synthetic Training Data</article-title><source>Nanomaterials</source><year>2022</year><volume>12</volume><elocation-id>1818</elocation-id><pub-id pub-id-type="doi">10.3390/nano12111818</pub-id><pub-id pub-id-type="pmid">35683674</pub-id>
</element-citation></ref><ref id="B24-pharmaceutics-17-00172"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guo</surname><given-names>D.</given-names></name>
<name><surname>Xie</surname><given-names>G.</given-names></name>
<name><surname>Luo</surname><given-names>J.</given-names></name>
</person-group><article-title>Mechanical properties of nanoparticles: Basics and applications</article-title><source>J. Phys. D Appl. Phys.</source><year>2014</year><volume>47</volume><fpage>013001</fpage><pub-id pub-id-type="doi">10.1088/0022-3727/47/1/013001</pub-id></element-citation></ref><ref id="B25-pharmaceutics-17-00172"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wickramaratne</surname><given-names>M.N.</given-names></name>
<name><surname>Punchihewa</surname><given-names>J.C.</given-names></name>
<name><surname>Wickramaratne</surname><given-names>D.B.M.</given-names></name>
</person-group><article-title>In-vitro alpha amylase inhibitory activity of the leaf extracts of <italic toggle="yes">Adenanthera pavonina</italic></article-title><source>BMC Complement. Altern. Med.</source><year>2016</year><volume>16</volume><elocation-id>466</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-016-1452-y</pub-id><pub-id pub-id-type="pmid">27846876</pub-id>
</element-citation></ref><ref id="B26-pharmaceutics-17-00172"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pistia-Brueggeman</surname><given-names>G.</given-names></name>
<name><surname>Hollingsworth</surname><given-names>R.I.</given-names></name>
</person-group><article-title>A preparation and screening strategy for glycosidase inhibitors</article-title><source>Tetrahedron</source><year>2001</year><volume>57</volume><fpage>8773</fpage><lpage>8778</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)00877-8</pub-id></element-citation></ref><ref id="B27-pharmaceutics-17-00172"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anosike</surname><given-names>C.A.</given-names></name>
<name><surname>Obidoa</surname><given-names>O.</given-names></name>
<name><surname>Ezeanyika</surname><given-names>L.U.</given-names></name>
</person-group><article-title>Membrane stabilization as a mechanism of the anti-inflammatory activity of methanol extract of garden egg (<italic toggle="yes">Solanum aethiopicum</italic>)</article-title><source>Daru</source><year>2012</year><volume>20</volume><fpage>76</fpage><pub-id pub-id-type="doi">10.1186/2008-2231-20-76</pub-id><pub-id pub-id-type="pmid">23351977</pub-id>
</element-citation></ref><ref id="B28-pharmaceutics-17-00172"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shinde</surname><given-names>U.A.</given-names></name>
<name><surname>Phadke</surname><given-names>A.S.</given-names></name>
<name><surname>Nair</surname><given-names>A.M.</given-names></name>
<name><surname>Mungantiwar</surname><given-names>A.A.</given-names></name>
<name><surname>Dikshit</surname><given-names>V.J.</given-names></name>
<name><surname>Saraf</surname><given-names>M.N.</given-names></name>
</person-group><article-title>Membrane stabilizing activity&#x02014;A possible mechanism of action for the anti-inflammatory activity of Cedrus deodara wood oil</article-title><source>Fitoterapia</source><year>1999</year><volume>70</volume><fpage>251</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1016/S0367-326X(99)00030-1</pub-id></element-citation></ref><ref id="B29-pharmaceutics-17-00172"><label>29.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>Clinical and Laboratory Standards Institute</collab>
</person-group><source>Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically</source><edition>12th ed.</edition><publisher-name>CLSI</publisher-name><publisher-loc>Wayne, PA, USA</publisher-loc><year>2012</year><volume>Volume 32</volume></element-citation></ref><ref id="B30-pharmaceutics-17-00172"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Magaldi</surname><given-names>S.</given-names></name>
<name><surname>Mata-Essayag</surname><given-names>S.</given-names></name>
<name><surname>Hartung de Capriles</surname><given-names>C.</given-names></name>
<name><surname>Perez</surname><given-names>C.</given-names></name>
<name><surname>Colella</surname><given-names>M.T.</given-names></name>
<name><surname>Olaizola</surname><given-names>C.</given-names></name>
<name><surname>Ontiveros</surname><given-names>Y.</given-names></name>
</person-group><article-title>Well diffusion for antifungal susceptibility testing</article-title><source>Int. J. Infect. Dis.</source><year>2004</year><volume>8</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2003.03.002</pub-id><pub-id pub-id-type="pmid">14690779</pub-id>
</element-citation></ref><ref id="B31-pharmaceutics-17-00172"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gonz&#x000e1;lez-Palma</surname><given-names>I.</given-names></name>
<name><surname>Escalona-Buend&#x000ed;a</surname><given-names>H.B.</given-names></name>
<name><surname>Ponce-Alquicira</surname><given-names>E.</given-names></name>
<name><surname>T&#x000e9;llez-T&#x000e9;llez</surname><given-names>M.</given-names></name>
<name><surname>Gupta</surname><given-names>V.K.</given-names></name>
<name><surname>D&#x000ed;az-God&#x000ed;nez</surname><given-names>G.</given-names></name>
<name><surname>Soriano-Santos</surname><given-names>J.</given-names></name>
</person-group><article-title>Evaluation of the Antioxidant Activity of Aqueous and Methanol Extracts of <italic toggle="yes">Pleurotus ostreatus</italic> in Different Growth Stages</article-title><source>Front. Microbiol.</source><year>2016</year><volume>7</volume><elocation-id>1099</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2016.01099</pub-id><pub-id pub-id-type="pmid">27462314</pub-id>
</element-citation></ref><ref id="B32-pharmaceutics-17-00172"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pietrzak</surname><given-names>W.</given-names></name>
<name><surname>Nowak</surname><given-names>R.</given-names></name>
<name><surname>Gawlik-Dziki</surname><given-names>U.</given-names></name>
<name><surname>Lemieszek</surname><given-names>M.K.</given-names></name>
<name><surname>Rzeski</surname><given-names>W.</given-names></name>
</person-group><article-title>LC-ESI-MS/MS Identification of Biologically Active Phenolic Compounds in Mistletoe Berry Extracts from Different Host Trees</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>624</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22040624</pub-id><pub-id pub-id-type="pmid">28417943</pub-id>
</element-citation></ref><ref id="B33-pharmaceutics-17-00172"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Slater</surname><given-names>T.F.</given-names></name>
<name><surname>Sawyer</surname><given-names>B.</given-names></name>
<name><surname>Straeuli</surname><given-names>U.</given-names></name>
</person-group><article-title>Studies on Succinate-tetrazolium Reductase Systems. III. Points of Coupling of Four Different Tetrazolium Salts</article-title><source>Biochim. Biophys. Acta</source><year>1963</year><volume>77</volume><fpage>383</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/0006-3002(63)90513-4</pub-id><pub-id pub-id-type="pmid">14089413</pub-id>
</element-citation></ref><ref id="B34-pharmaceutics-17-00172"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alley</surname><given-names>M.C.</given-names></name>
<name><surname>Scudiero</surname><given-names>D.A.</given-names></name>
<name><surname>Monks</surname><given-names>A.</given-names></name>
<name><surname>Hursey</surname><given-names>M.L.</given-names></name>
<name><surname>Czerwinski</surname><given-names>M.J.</given-names></name>
<name><surname>Fine</surname><given-names>D.L.</given-names></name>
<name><surname>Abbott</surname><given-names>B.J.</given-names></name>
<name><surname>Mayo</surname><given-names>J.G.</given-names></name>
<name><surname>Shoemaker</surname><given-names>R.H.</given-names></name>
<name><surname>Boyd</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay</article-title><source>Cancer Res.</source><year>1988</year><volume>48</volume><fpage>589</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">3335022</pub-id>
</element-citation></ref><ref id="B35-pharmaceutics-17-00172"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van de Loosdrecht</surname><given-names>A.A.</given-names></name>
<name><surname>Beelen</surname><given-names>R.H.</given-names></name>
<name><surname>Ossenkoppele</surname><given-names>G.J.</given-names></name>
<name><surname>Broekhoven</surname><given-names>M.G.</given-names></name>
<name><surname>Langenhuijsen</surname><given-names>M.M.</given-names></name>
</person-group><article-title>A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia</article-title><source>J. Immunol. Methods</source><year>1994</year><volume>174</volume><fpage>311</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(94)90034-5</pub-id><pub-id pub-id-type="pmid">8083535</pub-id>
</element-citation></ref><ref id="B36-pharmaceutics-17-00172"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qanash</surname><given-names>H.</given-names></name>
<name><surname>Bazaid</surname><given-names>A.S.</given-names></name>
<name><surname>Binsaleh</surname><given-names>N.K.</given-names></name>
<name><surname>Patel</surname><given-names>M.</given-names></name>
<name><surname>Althomali</surname><given-names>O.W.</given-names></name>
<name><surname>Sheeha</surname><given-names>B.B.</given-names></name>
</person-group><article-title>In Vitro Antiproliferative Apoptosis Induction and Cell Cycle Arrest Potential of Saudi Sidr Honey against Colorectal Cancer</article-title><source>Nutrients</source><year>2023</year><volume>15</volume><elocation-id>3448</elocation-id><pub-id pub-id-type="doi">10.3390/nu15153448</pub-id><pub-id pub-id-type="pmid">37571386</pub-id>
</element-citation></ref><ref id="B37-pharmaceutics-17-00172"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fran&#x000e7;a</surname><given-names>T.</given-names></name>
<name><surname>Gon&#x000e7;alves</surname><given-names>D.A.</given-names></name>
<name><surname>Cena</surname><given-names>C.</given-names></name>
</person-group><article-title>ATR-FTIR spectroscopy combined with machine learning for classification of PVA/PVP blends in low concentration</article-title><source>Vib. Spectrosc.</source><year>2022</year><volume>120</volume><fpage>103378</fpage><pub-id pub-id-type="doi">10.1016/j.vibspec.2022.103378</pub-id></element-citation></ref><ref id="B38-pharmaceutics-17-00172"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sameh</surname><given-names>A.</given-names></name>
<name><surname>Gouda</surname><given-names>A.A.</given-names></name>
<name><surname>Elmligy</surname><given-names>E.</given-names></name>
<name><surname>Hatem</surname><given-names>H.</given-names></name>
<name><surname>Sadek</surname><given-names>S.S.</given-names></name>
<name><surname>Ahmed</surname><given-names>O.</given-names></name>
<name><surname>El Amir</surname><given-names>A.</given-names></name>
</person-group><article-title>Bee venom as an alternative for antibiotics against Staphylococcus aureus infections</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><elocation-id>6436</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-023-33536-x</pub-id><pub-id pub-id-type="pmid">37081055</pub-id>
</element-citation></ref><ref id="B39-pharmaceutics-17-00172"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vivek</surname><given-names>C.</given-names></name>
<name><surname>Balraj</surname><given-names>B.</given-names></name>
<name><surname>Thangavel</surname><given-names>S.</given-names></name>
</person-group><article-title>Structural, optical and electrical behavior of ZnO@Ag core&#x02013;shell nanocomposite synthesized via novel plasmon-green mediated approach</article-title><source>J. Mater. Sci. Mater. Electron.</source><year>2019</year><volume>30</volume><fpage>11220</fpage><lpage>11230</lpage><pub-id pub-id-type="doi">10.1007/s10854-019-01467-x</pub-id></element-citation></ref><ref id="B40-pharmaceutics-17-00172"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aziz</surname><given-names>S.B.</given-names></name>
<name><surname>Abdulwahid</surname><given-names>R.T.</given-names></name>
<name><surname>Rasheed</surname><given-names>M.A.</given-names></name>
<name><surname>Abdullah</surname><given-names>O.G.</given-names></name>
<name><surname>Ahmed</surname><given-names>H.M.</given-names></name>
</person-group><article-title>Polymer Blending as a Novel Approach for Tuning the SPR Peaks of Silver Nanoparticles</article-title><source>Polymers</source><year>2017</year><volume>9</volume><elocation-id>486</elocation-id><pub-id pub-id-type="doi">10.3390/polym9100486</pub-id><pub-id pub-id-type="pmid">30965789</pub-id>
</element-citation></ref><ref id="B41-pharmaceutics-17-00172"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>M.H.</given-names></name>
<name><surname>Jun</surname><given-names>H.S.</given-names></name>
<name><surname>Jeon</surname><given-names>J.W.</given-names></name>
<name><surname>Park</surname><given-names>J.K.</given-names></name>
<name><surname>Lee</surname><given-names>B.J.</given-names></name>
<name><surname>Suh</surname><given-names>G.H.</given-names></name>
<name><surname>Park</surname><given-names>J.S.</given-names></name>
<name><surname>Cho</surname><given-names>C.W.</given-names></name>
</person-group><article-title>Preparation and characterization of bee venom-loaded PLGA particles for sustained release</article-title><source>Pharm. Dev. Technol.</source><year>2018</year><volume>23</volume><fpage>857</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1080/10837450.2016.1264415</pub-id><pub-id pub-id-type="pmid">27881046</pub-id>
</element-citation></ref><ref id="B42-pharmaceutics-17-00172"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yedurkar</surname><given-names>S.</given-names></name>
<name><surname>Maurya</surname><given-names>C.</given-names></name>
</person-group><article-title>and Mahanwar, P. Biosynthesis of Zinc Oxide Nanoparticles Using Ixora Coccinea Leaf Extract&#x02014;A Green Approach</article-title><source>Open J. Synth. Theory Appl.</source><year>2016</year><volume>5</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.4236/ojsta.2016.51001</pub-id></element-citation></ref><ref id="B43-pharmaceutics-17-00172"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Allogmani</surname><given-names>A.S.</given-names></name>
<name><surname>Mohamed</surname><given-names>R.M.</given-names></name>
<name><surname>Hasanin</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Green, Eco-Friendly, Highly Biocompatible and Bioactive Nanocomposite-Based Biopolymers Loaded with ZnO@Fe3O4 Nanoparticles</article-title><source>Polymers</source><year>2023</year><volume>15</volume><elocation-id>3641</elocation-id><pub-id pub-id-type="doi">10.3390/polym15173641</pub-id><pub-id pub-id-type="pmid">37688268</pub-id>
</element-citation></ref><ref id="B44-pharmaceutics-17-00172"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jahan</surname><given-names>Z.</given-names></name>
<name><surname>Niazi</surname><given-names>M.B.K.</given-names></name>
<name><surname>Gregersen</surname><given-names>&#x000d8;.W.</given-names></name>
</person-group><article-title>Mechanical, thermal and swelling properties of cellulose nanocrystals/PVA nanocomposites membranes</article-title><source>J. Ind. Eng. Chem.</source><year>2018</year><volume>57</volume><fpage>113</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.jiec.2017.08.014</pub-id></element-citation></ref><ref id="B45-pharmaceutics-17-00172"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hassan</surname><given-names>A.K.</given-names></name>
<name><surname>El-kotby</surname><given-names>D.A.</given-names></name>
<name><surname>Tawfik</surname><given-names>M.M.</given-names></name>
<name><surname>Badr</surname><given-names>R.E.</given-names></name>
<name><surname>Bahgat</surname><given-names>I.M.</given-names></name>
</person-group><article-title>Antidiabetic effect of the Egyptian honey bee (<italic toggle="yes">Apis mellifera</italic>) venom in alloxan-induced diabetic rats</article-title><source>J. Basic Appl. Zool.</source><year>2019</year><volume>80</volume><fpage>58</fpage><pub-id pub-id-type="doi">10.1186/s41936-019-0127-x</pub-id></element-citation></ref><ref id="B46-pharmaceutics-17-00172"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khulan</surname><given-names>T.S.</given-names></name>
<name><surname>Ambaga</surname><given-names>M.</given-names></name>
<name><surname>Chimedragcha</surname><given-names>C.H.</given-names></name>
</person-group><article-title>Effect of honey bee venom (<italic toggle="yes">Apis mellifera</italic>) on hyperglycemia and hyperlipidemia in all oxen-induced diabetic rabbits</article-title><source>J. Diabetes Metab.</source><year>2015</year><volume>6</volume><fpage>2</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.4172/2155-6156.1000507</pub-id></element-citation></ref><ref id="B47-pharmaceutics-17-00172"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sadek</surname><given-names>K.M.</given-names></name>
<name><surname>Sobhy</surname><given-names>R.A.</given-names></name>
<name><surname>Sammak</surname><given-names>D.H.</given-names></name>
<name><surname>Zeweil</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Hypoglycemic and Hypolipidemic Biochemical Effects of Bee Venom on Experimentally Induced Diabetes in Rats</article-title><source>Alex. J. Vet. Sci.</source><year>2024</year><volume>81</volume><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.5455/ajvs.194500</pub-id></element-citation></ref><ref id="B48-pharmaceutics-17-00172"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ryu</surname><given-names>H.W.</given-names></name>
<name><surname>Cho</surname><given-names>J.K.</given-names></name>
<name><surname>Curtis-Long</surname><given-names>M.J.</given-names></name>
<name><surname>Yuk</surname><given-names>H.J.</given-names></name>
<name><surname>Kim</surname><given-names>Y.S.</given-names></name>
<name><surname>Jung</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>Y.S.</given-names></name>
<name><surname>Lee</surname><given-names>B.W.</given-names></name>
<name><surname>Park</surname><given-names>K.H.</given-names></name>
</person-group><article-title>&#x003b1;-Glucosidase inhibition and antihyperglycemic activity of prenylated xanthones from <italic toggle="yes">Garcinia mangostana</italic></article-title><source>Phytochemistry</source><year>2011</year><volume>72</volume><fpage>2148</fpage><lpage>2154</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2011.08.007</pub-id><pub-id pub-id-type="pmid">21872893</pub-id>
</element-citation></ref><ref id="B49-pharmaceutics-17-00172"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>G.</given-names></name>
<name><surname>Beta</surname><given-names>T.</given-names></name>
<name><surname>Dong</surname><given-names>J.</given-names></name>
</person-group><article-title>Inhibitory Properties of Aqueous Ethanol Extracts of Propolis on Alpha-Glucosidase</article-title><source>Evid.-Based Complement. Altern. Med.</source><year>2015</year><volume>2015</volume><fpage>587383</fpage><pub-id pub-id-type="doi">10.1155/2015/587383</pub-id></element-citation></ref><ref id="B50-pharmaceutics-17-00172"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bellik</surname><given-names>Y.</given-names></name>
</person-group><article-title>Bee Venom: Its Potential Use in Alternative Medicine</article-title><source>Anti-Infect. Agents</source><year>2015</year><volume>13</volume><fpage>3</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.2174/2211352513666150318234624</pub-id></element-citation></ref><ref id="B51-pharmaceutics-17-00172"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dadar</surname><given-names>M.</given-names></name>
<name><surname>Shahali</surname><given-names>Y.</given-names></name>
<name><surname>Chakraborty</surname><given-names>S.</given-names></name>
<name><surname>Prasad</surname><given-names>M.</given-names></name>
<name><surname>Tahoori</surname><given-names>F.</given-names></name>
<name><surname>Tiwari</surname><given-names>R.</given-names></name>
<name><surname>Dhama</surname><given-names>K.</given-names></name>
</person-group><article-title>Antiinflammatory peptides: Current knowledge and promising prospects</article-title><source>Inflamm. Res.</source><year>2019</year><volume>68</volume><fpage>125</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1007/s00011-018-1208-x</pub-id><pub-id pub-id-type="pmid">30560372</pub-id>
</element-citation></ref><ref id="B52-pharmaceutics-17-00172"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mostafa</surname><given-names>H.</given-names></name>
<name><surname>Masry</surname><given-names>S.</given-names></name>
<name><surname>Abou-Zeid</surname><given-names>M.</given-names></name>
<name><surname>Abd El Wahab</surname><given-names>A.</given-names></name>
<name><surname>El Demellawy</surname><given-names>M.</given-names></name>
<name><surname>Abdou</surname><given-names>D.</given-names></name>
</person-group><article-title>Antimicrobial and Anti-Biofilm Activities of Bee Venom against some Dental pathogens</article-title><source>Egypt. J. Pure Appl. Sci.</source><year>2022</year><volume>60</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.21608/ejaps.2022.142059.1035</pub-id></element-citation></ref><ref id="B53-pharmaceutics-17-00172"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El-Sayied Ali</surname><given-names>S.</given-names></name>
<name><surname>El-Ghannam</surname><given-names>G.</given-names></name>
<name><surname>Hashish</surname><given-names>M.E.-S.</given-names></name>
<name><surname>Elsayed</surname><given-names>H.</given-names></name>
<name><surname>Ali</surname><given-names>A.K.</given-names></name>
<name><surname>Marzouk</surname><given-names>W.M.</given-names></name>
<name><surname>Khattaby</surname><given-names>A.M.</given-names></name>
<name><surname>El-Wahab</surname><given-names>A.M.A.</given-names></name>
<name><surname>Abdel-Hafez</surname><given-names>S.H.</given-names></name>
<name><surname>Attia Attia</surname><given-names>Y.</given-names></name>
</person-group><article-title>Exploring bee venom and silver nanoparticles for controlling foulbrood pathogen and enhancing lifespan of honeybees</article-title><source>Sci. Rep.</source><year>2024</year><volume>14</volume><elocation-id>19013</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-024-67515-7</pub-id><pub-id pub-id-type="pmid">39152125</pub-id>
</element-citation></ref><ref id="B54-pharmaceutics-17-00172"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barnes</surname><given-names>A.M.T.</given-names></name>
<name><surname>Frank</surname><given-names>K.L.</given-names></name>
<name><surname>Dunny</surname><given-names>G.M.</given-names></name>
</person-group><article-title>Enterococcal Endocarditis: Hiding in Plain Sight</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2021</year><volume>11</volume><elocation-id>722482</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.722482</pub-id><pub-id pub-id-type="pmid">34527603</pub-id>
</element-citation></ref><ref id="B55-pharmaceutics-17-00172"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hegazi</surname><given-names>A.</given-names></name>
<name><surname>Abdou</surname><given-names>A.</given-names></name>
<name><surname>Abd El-Moez</surname><given-names>S.</given-names></name>
<name><surname>Abd</surname><given-names>F.</given-names></name>
</person-group><article-title>Evaluation of the Antibacterial Activity of Bee Venom from Different Sources</article-title><source>World Appl. Sci. J.</source><year>2014</year><volume>30</volume><fpage>266</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.5829/idosi.wasj.2014.30.03.82215</pub-id></element-citation></ref><ref id="B56-pharmaceutics-17-00172"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Somwongin</surname><given-names>S.</given-names></name>
<name><surname>Chantawannakul</surname><given-names>P.</given-names></name>
<name><surname>Chaiyana</surname><given-names>W.</given-names></name>
</person-group><article-title>Antioxidant activity and irritation property of venoms from Apis species</article-title><source>Toxicon</source><year>2018</year><volume>145</volume><fpage>32</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2018.02.049</pub-id><pub-id pub-id-type="pmid">29499244</pub-id>
</element-citation></ref><ref id="B57-pharmaceutics-17-00172"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Elswaby</surname><given-names>S.</given-names></name>
<name><surname>Sadik</surname><given-names>M.</given-names></name>
<name><surname>Azouz</surname><given-names>A.</given-names></name>
<name><surname>Emam</surname><given-names>N.</given-names></name>
<name><surname>Ali</surname><given-names>M.</given-names></name>
</person-group><article-title>In vitro evaluation of antimicrobial and antioxidant activities of honeybee venom and propolis collected from various regions in Egypt</article-title><source>Egypt. Pharm. J.</source><year>2022</year><volume>21</volume><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.4103/epj.epj_18_22</pub-id></element-citation></ref><ref id="B58-pharmaceutics-17-00172"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rivero-Cruz</surname><given-names>J.F.</given-names></name>
<name><surname>Granados-Pineda</surname><given-names>J.</given-names></name>
<name><surname>Pedraza-Chaverri</surname><given-names>J.</given-names></name>
<name><surname>P&#x000e9;rez-Rojas</surname><given-names>J.M.</given-names></name>
<name><surname>Kumar-Passari</surname><given-names>A.</given-names></name>
<name><surname>Diaz-Ruiz</surname><given-names>G.</given-names></name>
<name><surname>Rivero-Cruz</surname><given-names>B.E.</given-names></name>
</person-group><article-title>Phytochemical Constituents, Antioxidant, Cytotoxic, and Antimicrobial Activities of the Ethanolic Extract of Mexican Brown Propolis</article-title><source>Antioxidants</source><year>2020</year><volume>9</volume><elocation-id>70</elocation-id><pub-id pub-id-type="doi">10.3390/antiox9010070</pub-id><pub-id pub-id-type="pmid">31940981</pub-id>
</element-citation></ref><ref id="B59-pharmaceutics-17-00172"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nusair</surname><given-names>S.A.</given-names></name>
<name><surname>Galal</surname><given-names>G.</given-names></name>
<name><surname>Radwan</surname><given-names>S.M.</given-names></name>
</person-group><article-title>The potential anticancer effect of bee venom in combination with sorafenib against HepG2 cell lines via induction of apoptosis and autophagy candidate genes</article-title><source>Egypt. J. Med. Hum. Genet.</source><year>2024</year><volume>25</volume><fpage>49</fpage><pub-id pub-id-type="doi">10.1186/s43042-024-00524-3</pub-id></element-citation></ref><ref id="B60-pharmaceutics-17-00172"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kamel</surname><given-names>A.G.</given-names></name>
<name><surname>Sabet</surname><given-names>S.</given-names></name>
<name><surname>El-Shibiny</surname><given-names>A.</given-names></name>
</person-group><article-title>Potential mitochondrial ROS-mediated damage induced by chitosan nanoparticles bee venom-loaded on cancer cell lines</article-title><source>Int. J. Biol. Macromol.</source><year>2024</year><volume>279</volume><elocation-id>135362</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2024.135362</pub-id><pub-id pub-id-type="pmid">39245116</pub-id>
</element-citation></ref><ref id="B61-pharmaceutics-17-00172"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jadhav</surname><given-names>V.</given-names></name>
<name><surname>Bhagare</surname><given-names>A.</given-names></name>
<name><surname>Palake</surname><given-names>A.</given-names></name>
<name><surname>Kodam</surname><given-names>K.</given-names></name>
<name><surname>Dhaygude</surname><given-names>A.</given-names></name>
<name><surname>Kardel</surname><given-names>A.</given-names></name>
<name><surname>Lokhande</surname><given-names>D.</given-names></name>
<name><surname>Aher</surname><given-names>J.</given-names></name>
</person-group><article-title>In vitro cytotoxicity assessment of biosynthesized Apis mellifera bee venom nanoparticles (BVNPs) against MCF-7 breast cancer cell lines</article-title><source>Discover. Nano</source><year>2024</year><volume>19</volume><fpage>170</fpage><pub-id pub-id-type="doi">10.1186/s11671-024-04123-4</pub-id><pub-id pub-id-type="pmid">39402248</pub-id>
</element-citation></ref><ref id="B62-pharmaceutics-17-00172"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>Y.J.</given-names></name>
<name><surname>Kang</surname><given-names>S.J.</given-names></name>
<name><surname>Kim</surname><given-names>B.M.</given-names></name>
<name><surname>Kim</surname><given-names>Y.J.</given-names></name>
<name><surname>Woo</surname><given-names>H.D.</given-names></name>
<name><surname>Chung</surname><given-names>H.W.</given-names></name>
</person-group><article-title>Cytotoxicity of honeybee (Apis mellifera) venom in normal human lymphocytes and HL-60 cells</article-title><source>Chem. Biol. Interact.</source><year>2007</year><volume>169</volume><fpage>189</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2007.06.036</pub-id><pub-id pub-id-type="pmid">17658502</pub-id>
</element-citation></ref><ref id="B63-pharmaceutics-17-00172"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>R.</given-names></name>
<name><surname>Rana</surname><given-names>A.</given-names></name>
</person-group><article-title>Chemical Profiling of Bee Venom and Beeswax: A GC-MS Analysis</article-title><source>Bioscene</source><year>2024</year><volume>21</volume><fpage>228</fpage><lpage>240</lpage></element-citation></ref><ref id="B64-pharmaceutics-17-00172"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thangaleela</surname><given-names>S.</given-names></name>
<name><surname>Sivamaruthi</surname><given-names>B.S.</given-names></name>
<name><surname>Kesika</surname><given-names>P.</given-names></name>
<name><surname>Tiyajamorn</surname><given-names>T.</given-names></name>
<name><surname>Bharathi</surname><given-names>M.</given-names></name>
<name><surname>Chaiyasut</surname><given-names>C.</given-names></name>
</person-group><article-title>A Narrative Review on the Bioactivity and Health Benefits of Alpha-Phellandrene</article-title><source>Sci. Pharm.</source><year>2022</year><volume>90</volume><elocation-id>57</elocation-id><pub-id pub-id-type="doi">10.3390/scipharm90040057</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="pharmaceutics-17-00172-f001"><label>Figure 1</label><caption><p>FTIR spectra of pure PVA, BV, PVA/BV, and nanofilm.</p></caption><graphic xlink:href="pharmaceutics-17-00172-g001" position="float"/></fig><fig position="float" id="pharmaceutics-17-00172-f002"><label>Figure 2</label><caption><p>XRD pattern of pure PVA, BV, PVA/BV, and nanofilm.</p></caption><graphic xlink:href="pharmaceutics-17-00172-g002" position="float"/></fig><fig position="float" id="pharmaceutics-17-00172-f003"><label>Figure 3</label><caption><p>SEM images of pure PVA and nanofilm with low and high magnifications together with the EDX charts of BV and nanofilm.</p></caption><graphic xlink:href="pharmaceutics-17-00172-g003" position="float"/></fig><fig position="float" id="pharmaceutics-17-00172-f004"><label>Figure 4</label><caption><p>The HR-TEM images of nanofilm with (<bold>A</bold>) low (left) and (<bold>B</bold>) high (right) magnifications.</p></caption><graphic xlink:href="pharmaceutics-17-00172-g004" position="float"/></fig><fig position="float" id="pharmaceutics-17-00172-f005"><label>Figure 5</label><caption><p>Inhibition of RBCs hemolysis by (<bold>a</bold>) nanofilm, (<bold>b</bold>) PVA-BV, (<bold>c</bold>) PVA-B, (<bold>d</bold>) BV; C, control.</p></caption><graphic xlink:href="pharmaceutics-17-00172-g005" position="float"/></fig><fig position="float" id="pharmaceutics-17-00172-f006"><label>Figure 6</label><caption><p>Antimicrobial activity against (<bold>a</bold>) <italic toggle="yes">B. subtilis</italic> ATCC 6633, (<bold>b</bold>) <italic toggle="yes">S. aureus</italic> ATCC 6538, (<bold>c</bold>) <italic toggle="yes">E. coli</italic> ATCC 8739, (<bold>d</bold>) <italic toggle="yes">S. typhi</italic> ATCC 6539, (<bold>e</bold>) <italic toggle="yes">C. albicans</italic> ATCC 10221, (<bold>f</bold>) <italic toggle="yes">A. brasiliensis</italic> ATCC 16888.</p></caption><graphic xlink:href="pharmaceutics-17-00172-g006" position="float"/></fig><fig position="float" id="pharmaceutics-17-00172-f007"><label>Figure 7</label><caption><p>Cytotoxicity of BV and nanofilm on HepG2 cell line. (<bold>a</bold>) HepG2 cell line in liver tissues as a positive control, (<bold>b</bold>) different concentrations of BV, and (<bold>c</bold>) different concentrations of nanofilm for testing cytotoxicity.</p></caption><graphic xlink:href="pharmaceutics-17-00172-g007a" position="float"/><graphic xlink:href="pharmaceutics-17-00172-g007b" position="float"/></fig><fig position="float" id="pharmaceutics-17-00172-f008"><label>Figure 8</label><caption><p>(<bold>a</bold>) Effect of BV on HepG2 cell line with an IC<sub>50</sub> of 18.5 &#x000b1; 0.08 &#x000b5;g/mL. (<bold>b</bold>) Effect of nanofilm on HepG2 cell line with an IC<sub>50</sub> of 52.27 &#x000b1; 0.7 &#x000b5;g/mL.</p></caption><graphic xlink:href="pharmaceutics-17-00172-g008" position="float"/></fig><fig position="float" id="pharmaceutics-17-00172-f009"><label>Figure 9</label><caption><p>Microanalyses of BV components using (<bold>A</bold>) total in chromatogram (TIC); (<bold>B</bold>) mass spectrum with the highest intensity EPI (100&#x02013;1000) from 10.934 min and precursor: 712.5 Da, CE: 35; (<bold>C</bold>) mass spectrum with the highest intensity EPI (100&#x02013;1000) from 10.726 min and precursor: 712.2 Da, CE: 35; (<bold>D</bold>) mass spectrum with the highest intensity EPI (100&#x02013;1000) from 10.520 min and precursor: 570.2 Da, CE: 35.</p></caption><graphic xlink:href="pharmaceutics-17-00172-g009" position="float"/></fig><table-wrap position="float" id="pharmaceutics-17-00172-t001"><object-id pub-id-type="pii">pharmaceutics-17-00172-t001_Table 1</object-id><label>Table 1</label><caption><p>In vitro assay of &#x003b1;-amylase inhibitory activity using standard acarbose, nanofilm, BV, PVA-B (blank), and PVA-BV.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">S *</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Factors</th><th colspan="11" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Concentrations (&#x000b5;g/mL)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">IC<sub>50</sub><break/>(&#x000b5;g/mL)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.95</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.9</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.8</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.5</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1000</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Acarbose</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.257</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.788</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.667</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.551</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.425</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.317</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.228</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.134</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.099</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.071</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.041</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">4.01</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">74.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">81.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96.80</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Nanofilm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.257</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.208</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.937</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.826</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.708</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.594</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.484</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.375</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.257</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.160</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.098</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">30.33</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.900</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">61.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92.20</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.279</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.091</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">BV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.257</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.084</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.958</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.840</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.715</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.577</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.466</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.349</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.233</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.134</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">51.69</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">81.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89.30</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PVA-B *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.257</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.254</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.254</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.253</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.250</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.247</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.238</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.233</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.229</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.118</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.918</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">None</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.300</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.300</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.800</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.500</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.900</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.00</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PVA-BV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.257</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.248</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.233</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.202</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.970</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.856</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.652</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.554</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.443</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.323</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">182</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.700</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.900</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.400</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">74.30</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.008</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>* S, sample; B, blank; E, enzyme; C, control; SD, standard deviation; SE, standard error; A, absorbance.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pharmaceutics-17-00172-t002"><object-id pub-id-type="pii">pharmaceutics-17-00172-t002_Table 2</object-id><label>Table 2</label><caption><p>In vitro assay of &#x003b1;-glucosidase inhibitory activity using standard acarbose, nanofilm, BV, PVA-B (blank), and PVA-BV.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">S</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Factors</th><th colspan="11" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Concentrations (&#x000b5;g/mL)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">IC<sub>50</sub><break/>(&#x000b5;g/mL)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.95</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.9</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.8</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.5</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1000</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Acarbose</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.817</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.983</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.861</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.735</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.620</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.501</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.393</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.284</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.213</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.106</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.047</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">2.57</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">78.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97.40</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Nanofilm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.817</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.106</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.967</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.846</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.729</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.605</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.489</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.378</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.258</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.125</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.065</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">5.55</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96.40</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.010</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">BV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.817</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.179</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.011</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.886</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.773</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.647</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.514</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.401</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.269</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.170</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.112</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">7.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">71.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93.90</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PVA-B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.817</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.723</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.642</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.546</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.431</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.343</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.279</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.158</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.072</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.855</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">736.78</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.90</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.011</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.028</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.009</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PVA-BV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.817</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.279</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.158</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.911</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.778</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.675</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.562</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.461</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.295</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.231</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">16.05</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">74.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87.30</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.105</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.034</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr></tbody></table><table-wrap-foot><fn><p>S, sample; B, blank; E, enzyme; C, control; SD, standard deviation; SE, standard error; A, absorbance.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pharmaceutics-17-00172-t003"><object-id pub-id-type="pii">pharmaceutics-17-00172-t003_Table 3</object-id><label>Table 3</label><caption><p>In vitro assay of anti-inflammatory activity using standard indomethacin, nanofilm, BV, PVA-B (blank), and PVA-BV.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">S</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Factors</th><th colspan="10" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Concentrations (&#x000b5;g/mL)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">IC<sub>50</sub><break/>(&#x000b5;g/mL)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.9</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.8</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.5</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1000</th></tr></thead><tbody><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">IND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.963</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.563</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.445</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.377</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.319</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.215</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.140</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.085</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.056</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.023</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">5.86</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A<sub>540</sub> (IS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.017</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">78.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.40</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Nanofilm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.963</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.719</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.616</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.489</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.386</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.281</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.159</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.108</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.083</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.056</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">16.99</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A<sub>540</sub> (IS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.023</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.032</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.044</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">71.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">98.70</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">BV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.963</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.887</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.793</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.702</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.611</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.499</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.417</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.324</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.244</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.152</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">72.99</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A<sub>540</sub> (IS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.023</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.032</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.044</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.900</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.20</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.063</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PVA-B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.963</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.820</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.730</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.647</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.530</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.418</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.316</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.205</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.134</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.107</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">41.27</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A<sub>540</sub> (IS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.023</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.032</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.044</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93.10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PVA-BV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>540</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.963</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.737</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.652</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.518</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.437</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.309</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.216</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.163</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.110</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.089</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">22.12</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A<sub>540</sub> (IS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.023</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.032</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.044</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H-inhibition (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95.10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.009</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td></tr></tbody></table><table-wrap-foot><fn><p>S, sample; IND, indomethacin; B, blank; H, hemolysis; IS, isotonic solution; C, control; SD, standard deviation; SE, standard error; A, absorbance.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pharmaceutics-17-00172-t004"><object-id pub-id-type="pii">pharmaceutics-17-00172-t004_Table 4</object-id><label>Table 4</label><caption><p>In vitro analysis of antimicrobial activity of nanofilm, BV, PVA-B (blank), and PVA-BV.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Taxon</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Pathogen</th><th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Antimicrobial Activity (mm) of Sample</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BV</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PVA-BV</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PVA-B</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nanofilm</th></tr></thead><tbody><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Gram-positive bacteria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">B. subtilis</italic> ATCC 6633</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 &#x000b1; 0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 &#x000b1; 0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 &#x000b1; 0.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. aureus</italic> ATCC 6538</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 &#x000b1; 0.2</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Gram-negative bacteria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> ATCC 8739</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 &#x000b1; 0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 &#x000b1; 0.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. typhi</italic> ATCC 6539</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 &#x000b1; 0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 &#x000b1; 0.1</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Molds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">C. albicans</italic> ATCC 10221</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32 &#x000b1; 0.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">A. brasiliensis</italic> ATCC 16888</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 &#x000b1; 0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 &#x000b1; 0.1</td></tr></tbody></table><table-wrap-foot><fn><p>B, blank; NA, no activity. Gentamycin (50 &#x000b5;g/mL) is a control for bacteria; fluconazole (32 &#x000b5;g/mL) is a control for molds.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pharmaceutics-17-00172-t005"><object-id pub-id-type="pii">pharmaceutics-17-00172-t005_Table 5</object-id><label>Table 5</label><caption><p>Determination of MIC and MBC of nanofilm, BV, and PVA-BV.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Pathogen</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">MIC (&#x000b5;g/mL)</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">MBC (&#x000b5;g/mL)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BV</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PVA-BV</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nanofilm</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BV</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PVA-BV</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nanofilm</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">B. subtilis</italic> ATCC 6633</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. aureus</italic> ATCC 6538</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> ATCC 8739</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. typhi</italic> ATCC 6539</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.50</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">C. albicans</italic> ATCC 10221</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td></tr></tbody></table><table-wrap-foot><fn><p>MIC, minimum inhibitory concentration; MBC, minimum bactericidal concentration.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pharmaceutics-17-00172-t006"><object-id pub-id-type="pii">pharmaceutics-17-00172-t006_Table 6</object-id><label>Table 6</label><caption><p>In vitro assay of antioxidant activity using standard ascorbic acid, nanofilm, BV, PVA-B (blank), and PVA-BV.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">S</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Factors</th><th colspan="11" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Concentrations (&#x000b5;g/mL)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">IC<sub>50</sub><break/>(&#x000b5;g/mL)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.95</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.9</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.8</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.5</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1000</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">AA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>517</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.591</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.882</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.734</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.640</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.519</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.393</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.252</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.136</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.094</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.058</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.030</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">2.35</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH scav. (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">75.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">98.10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Nanofilm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>517</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.591</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.946</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.827</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.695</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.587</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.502</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.391</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.285</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.181</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.106</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.085</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">4.26</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH scav. (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">63.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">75.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94.70</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">BV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>517</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.591</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.183</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.062</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.942</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.831</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.706</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.595</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.492</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.373</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.261</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.158</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">19.43</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH scav. (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">76.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90.10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PVA-B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>517</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.591</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.556</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.538</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.520</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.478</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.390</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.289</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.102</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.961</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.802</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.677</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">818.41</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH scav. (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.300</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.400</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57.40</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PVA-BV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>517</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.591</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.993</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.871</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.747</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.636</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.524</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.430</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.318</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.212</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.142</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.105</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">5.84</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH scav. (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93.40</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td></tr></tbody></table><table-wrap-foot><fn><p>S, sample; AA, ascorbic acid; B, blank; C, control; SD, standard deviation; SE, standard error; A, absorbance.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pharmaceutics-17-00172-t007"><object-id pub-id-type="pii">pharmaceutics-17-00172-t007_Table 7</object-id><label>Table 7</label><caption><p>Cytotoxicity of BV and nanofilm on HepG2 cell line.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Conc. (&#x000b5;g/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mean A<sub>560</sub></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Viability (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Toxicity (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SE</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub> &#x000b1; SD (&#x000b5;g/mL)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HepG2 cell line</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.722</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002887</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-----------</td></tr><tr><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">BV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.816251154</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97.18374885</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001453</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.5 &#x000b1; 0.08</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.022</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.047091413</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96.95290859</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001528</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.5 &#x000b1; 0.08</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.025</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.462603878</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96.53739612</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001732</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.5 &#x000b1; 0.08</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.057</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.894736842</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92.10526316</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002082</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.5 &#x000b1; 0.08</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.343</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.59926131</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.40073869</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004410</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.5 &#x000b1; 0.08</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.810</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.705</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97.73776547</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.262234534</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006692</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.5 &#x000b1; 0.08</td></tr><tr><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Nanofilm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.037</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.12465374</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94.87534626</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003606</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.27 &#x000b1; 0.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.061</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.541089566</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.45891043</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002028</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.27 &#x000b1; 0.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.241</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.47183749</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66.52816251</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006489</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.27 &#x000b1; 0.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.635</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.04247461</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.95752539</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006333</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.27 &#x000b1; 0.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.720</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.81532779</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.184672207</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001202</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.27 &#x000b1; 0.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.810</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.721</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.9076639</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.092336103</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002028</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.27 &#x000b1; 0.7</td></tr></tbody></table><table-wrap-foot><fn><p>SD, standard deviation; SE, standard error.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pharmaceutics-17-00172-t008"><object-id pub-id-type="pii">pharmaceutics-17-00172-t008_Table 8</object-id><label>Table 8</label><caption><p>Components of BV based on microanalysis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RT (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Height</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Area</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RT (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Height</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Area</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenylhydrazine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.038317</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,359,283</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.69 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IAA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.470867</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">948,240.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.02 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,4-benzoquinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.100533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,172,849</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.17 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MTE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.56935</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9,819,045</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.43 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytosine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.100533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.90 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.78 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCALS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.56935</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,479,700</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.26 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1-methylhistamine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.100533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.16 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.94 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Creatinine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.645717</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">937,919.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.37 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L-aspartic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.100533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.06 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.16 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCALS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.745333</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6,324,281</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.04 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L-&#x003b2;-homothreonine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.100533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.06 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.16 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Creatinine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.92655</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,375,321</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.75 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L-&#x003b2;-homotyrosine-HCl</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.100533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6,995,533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.28 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCALS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.105233</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2,293,368</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.49 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NPP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.100533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,402,951</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.66 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DHGP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.647417</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2,531,331</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.33 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N,N-dimethylglycine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.185783</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.83 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.08 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">trans</italic>-Cinnamate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.9459</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7,588,287</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.60 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Histamine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.185783</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.01 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.63 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pyridoxine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.401083</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,333,806</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.00 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adenine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2593</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.75 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.98 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,4-Benzoquinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.730533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,552,315</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.95 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adenine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2593</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.75 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.95 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyrrhizate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.960783</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7,946,545</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.19 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HAA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2593</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.67 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.18 &#x000d7; 10<sup>9</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IBPPA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.03055</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2,657,344</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.33 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">cis</italic>-aconitate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2593</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.71 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.21 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCALS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.212983</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,458,333</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.78 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-pyridoxate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2593</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.07 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.19 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dihydrocapsaicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.791934</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,730,243</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.79 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Histamine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.328533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.94 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.94 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PDG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.990833</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7,315,209</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.00 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P-hydroxybenzoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.38935</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.92 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.05 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyrrhizate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.073916</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,187,500</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.80 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guanine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.435283</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.91 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.17 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DAMP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.343884</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">813,496.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.57 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenaturic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.435283</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2,697,917</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.57 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Esculin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.813416</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2,678,536</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.40 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carnosine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.435283</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.13 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.50 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UMP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.382533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2,979,774</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.79 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carnosine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.435283</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.13 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.96 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UMP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.382533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2,979,774</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.11 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypoxanthine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.4947</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.45 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.94 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NADH</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.85075</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6,150,434</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.09 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N-acetyl-L-Cysteine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.4947</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8,048,392</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.57 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.23113</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,386,385</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.52 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L-methionine sulfone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.4947</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.18 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.34 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KRR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.33495</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,699,226</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.30 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tyr</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.4947</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.18 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.34 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DGPSA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.23322</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,514,209</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.28 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Histamine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.572317</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.45 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.97 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dihydrosphingosine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.22845</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2,512,405</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Histamine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.572317</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.45 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.44 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Etidronate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.47452</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2,209,014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.36 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N-isovaleroylglycine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.572317</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.14 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.32 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MHGP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.03983</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,104,625</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.65 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HMPPE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.572317</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,544,233</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.17 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MSPG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.54685</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,843,891</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.36 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uric acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.6829</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,990,202</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.77 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Creatinine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.13187</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,952,579</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.73 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cysteine S-sulfate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.78405</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.59 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.08 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Etidronate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.6648</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,927,646</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.90 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DCA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.78405</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.35 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.78 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xylitol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.34558</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6,596,503</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.66 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NPP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.78405</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,439,595</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.60 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isoguvacine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.56753</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.21 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.83 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carnosine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.78405</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.45 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.25 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isoguvacine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.68405</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.14 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.68 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PSA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.862533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6,396,178</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.22 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isoguvacine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.34783</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.15 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.11 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HICA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.28075</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4,375,156</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.77 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">trans-Cinnamate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.55965</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,016,423</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.99 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quisqualate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.28075</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,740,382</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.14 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isoguvacine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.78005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.27 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.12 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N-acetylglutamate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.28075</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,740,557</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.05 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isoguvacine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.00437</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.20 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.81 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PSA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.28075</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,469,233</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.54 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerulenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.33712</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,365,315</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.61 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCALS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.1939</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6,083,586</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.60 &#x000d7; 10<sup>8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerulenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.5104</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,407,139</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.71 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenylhydrazine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.3769</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4,312,904</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.04 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Etidronate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.61048</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2,563,221</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.73 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCALS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.3769</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,979,634</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.59 &#x000d7; 10<sup>7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>HMPPE, 3,4-hydroxy-3-methoxyphenyl-prop-2-enoic acid; DCA, 3,4-dimethoxycinnamic acid; NPP, 4-nitrophenyl phosphate; HAA, 3-hydroxyanthranilic acid; PSA, piperacillin sodium salt; HICA, 1H-indole-3-carboxylic acid; PCALS, n-propionyl coenzyme A lithium salt; IAA, &#x003b2;-indoleacetic acid; MTE, 4-methyl-5-thiazoleethanol; DHGP, 1-decanoyl-2-hydroxy-sn-glycero-3-phosphocholine; IBPPA, 2-(4-isobutylphenyl) propionic acid; PDG, 3-phospho-D-glycerate; DAMP, 2&#x02032;-deoxyadenosine 5&#x02032;-monophosphate; UMP, uridine 5&#x02032;-monophosphate; NADH, nicotinamide adenine dinucleotide H; GDM, guanosine 5&#x02032;-diphosphate-D-mannose; KRR, Kaempferol-3-O-robinoside-7-O-rhamnoside; DGPSA, 1,2-dipalmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) sodium salt; MHGP, 1-myristoyl-2-hydroxy-sn-glycero-3-phosphate; MSPG, 3-(Methylsulfinyl) propylglucosinolate.</p></fn></table-wrap-foot></table-wrap></floats-group></article>